FGL (FGLHF) 10-Q 6 May 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - shares	3 Months Ended
	Mar. 31, 2020	Nov. 02, 2019
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	001-37779
Entity Registrant Name	FGL HOLDINGS
Entity Central Index Key	0001668428
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1354810
Entity Address, Address Line One	4th Floor
Entity Address, Address Line Two	Boundary Hall, Cricket Square
Entity Address, City or Town	Grand Cayman
Entity Address, Country	KY
Entity Address, Postal Zip Code	KY1-1102
City Area Code	800
Local Phone Number	445-6758
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		221,972,605
Ordinary shares, par value $.0001 per share
Entity Information [Line Items]
Title of 12(b) Security	Ordinary shares, par value $.0001 per share
Trading Symbol	FG
Security Exchange Name	NYSE
Warrants to purchase ordinary shares
Entity Information [Line Items]
Title of 12(b) Security	Warrants to purchase ordinary shares
Trading Symbol	FG WS
Security Exchange Name	NYSE

Investments - Proceeds From The

Investments - Proceeds From The Sale of Fixed-maturity available for-sale-securities - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Document Period End Date	Mar. 31, 2020
Available-for-sale Securities
Debt Securities, Available-for-sale [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:	$ 845	$ 962
Available-for-sale Securities | Total fixed maturities
Debt Securities, Available-for-sale [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:	462	474
Gain on sale of investments	16	5
Loss on Sale of Investments	$ 3	$ 10

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Investments:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2020 - $22,836; December 31, 2019 - $22,914 and allowance for expected credit losses: March 31, 2020 - $44; December 31, 2019 - $0)	$ 21,140	$ 23,726
Equity securities, at fair value (cost: March 31, 2020 - $1,052; December 31, 2019 - $1,069)	915	1,071
Derivative investments, at fair value	188	587
Mortgage loans (allowance for expected credit losses: March 31, 2020 - $12; December 31, 2019 - $0)	1,769	1,267
Other invested assets	1,491	1,303
Total investments	25,503	27,954
Cash and cash equivalents	776	969
Accrued investment income	251	228
Funds withheld for reinsurance receivables, at fair value	2,050	2,172
Reinsurance recoverable (allowance for expected credit losses: March 31, 2020 - $22; December 31, 2019 - $0)	3,186	3,213
Intangibles, net	2,029	1,455
Deferred tax assets, net	264	61
Goodwill	467	467
Other assets	211	195
Total assets	34,737	36,714
LIABILITIES AND SHAREHOLDERS' EQUITY
Contractholder funds	26,226	25,684
Future policy benefits, including $1,904 and $1,953 at fair value at March 31, 2020 and December 31, 2019, respectively	5,658	5,735
Funds Held under Reinsurance Agreements, Liability	821	831
Liability for policy and contract claims	73	71
Debt	543	542
Other liabilities	944	1,108
Total liabilities	34,265	33,971
Commitments and contingencies (Note 12)
Shareholders' equity:
Preferred stock ($.0001 par value, 100,000,000 shares authorized, 437,841 and 429,789 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively)	0	0
Common stock ($.0001 par value, 800,000,000 shares authorized, 221,972,605 and 221,807,598 issued and outstanding at March 31, 2020 and December 31, 2019, respectively	0	0
Additional paid-in capital	2,041	2,031
Retained earnings (Accumulated deficit)	(72)	300
Accumulated other comprehensive income (loss)	(1,428)	481
Treasury Stock, Value	69	69
Total shareholders' equity	472	$ 2,743
Total liabilities and shareholders' equity	$ 34,737

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Fixed maturity securities, available-for-sale, at fair value (amortized cost)	$ 22,836
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	800,000,000	800,000,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues:
Premiums	$ 10	$ 16
Net investment income	317	289
Net investment gains (losses)	(692)	240
Insurance and investment product fees and other	30	55
Total revenues	(335)	600
Benefits and expenses:
Benefits and other changes in policy reserves	(41)	339
Acquisition and operating expenses, net of deferrals	96	44
Amortization of intangibles	(61)	29
Total benefits and expenses	(6)	412
Operating income (loss)	(329)	188
Interest expense	(8)	(8)
Income (loss) before income taxes	(337)	180
Income tax (expense) benefit	(1)	(9)
Net income (loss)	(338)	171
Less Preferred stock dividend	8	8
Net income (loss) available to common shareholders	$ (346)	$ 163
Net income per common share
Basic (in USD per share)	$ (1.62)	$ 0.74
Diluted (in USD per share)	$ (1.62)	$ 0.74
Weighted average common shares used in computing net income (loss) per common share:
Basic (in shares)	213,155,198	219,645,679
Diluted (in shares)	213,155,198	219,681,679
Cash dividend per common share (in dollars per share)	$ 0.01	$ 0.01
Total other-than-temporary impairments	$ 0	$ (2)
Net other-than-temporary impairments		(2)
Gains (losses) on derivatives and embedded derivatives	(523)	164
Other investment gains (losses)	(121)	78
Net investment gains (losses)	$ (692)	$ 240

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net income (loss)	$ (338)	$ 171
Unrealized Gain (Loss) on Investments
Change in unrealized gains/losses on investments, net of adjustments to intangible assets and unearned revenue	(2,115)	779
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	6	(3)
Net changes to derive comprehensive income (loss) for the period	(1,909)	721
Comprehensive income (loss), net of tax	$ (2,247)	$ 892

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Preferred Stock	Ordinary shares, par value $.0001 per share	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock [Member]	Ordinary shares, par value $.0001 per share	Ordinary shares, par value $.0001 per shareAdditional Paid-in Capital	Ordinary shares, par value $.0001 per shareRetained Earnings (Accumulated Deficit)	Preferred Stock	Preferred StockAdditional Paid-in Capital	Preferred StockRetained Earnings (Accumulated Deficit)
Beginning Balance at Dec. 31, 2018	$ 890	$ 0	$ 0	$ 1,998	$ (167)	$ (937)	$ (4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	0			8	(8)
Net income (loss)	171				171
Unrealized investment losses, net	724					724
Ending Balance at Mar. 31, 2019	1,781	0	0	2,007	(6)	(216)	(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(3)					(3)
Beginning Balance at Dec. 31, 2019	2,743	0	0	2,031	300	481	(69)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends								$ (2)	$ 0	$ (2)	$ 0	$ 8	$ (8)
Net income (loss)	(338)				(338)
Unrealized investment losses, net	(1,915)					(1,915)
Ending Balance at Mar. 31, 2020	472	$ 0	$ 0	2,041	$ (72)	(1,428)	$ (69)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	6					$ 6
Stock Issued During Period, Value, Stock Dividend	$ 2			$ 2

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income (loss)	$ (338)	$ 171
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Stock based compensation	3	1
Amortization	10	4
Increase (Decrease) in Deferred Income Taxes	4	5
Interest credited/index credits to contractholder account balances	31	308
Net recognized (gains) losses on investments and derivatives	692	(240)
Charges assessed to contractholders for mortality and administration	(38)	(32)
Intangibles, net	(180)	(90)
Changes in operating assets and liabilities:
Reinsurance recoverable	(15)	(16)
Future policy benefits reflected in net income (loss)	(71)	36
Funds withheld for reinsurers	(98)	(129)
Collateral (returned) posted	(272)	141
Other assets and other liabilities	7	(63)
Net Cash Provided by (Used in) Operating Activities	(265)	96
Cash flows from investing activities:
Proceeds from mortgage loans	81	4
Costs of mortgage loans	596	12
Capital expenditures	(3)	(1)
Net cash provided by (used in) investing activities	(521)	404
Cash flows from financing activities:
Treasury stock	0	30
Common stock dividends paid	(2)	(2)
Contractholder account deposits	1,113	1,225
Contractholder account withdrawals	(518)	(907)
Net cash provided by (used in) financing activities	593	286
Change in cash and cash equivalents	(193)	786
Cash and cash equivalents, beginning of period	969
Cash and cash equivalents, end of period	776	1,357
Supplemental disclosures of cash flow information:
Income taxes (refunded) paid	0	(1)
Deferred sales inducements	27	35
Available-for-sale Securities
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	845	962
Cost of available-for-sale investments:	(675)	(421)
Derivative and other
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	136	44
Cost of available-for-sale investments:	$ (309)	$ (172)

Basis of Presentation and Natur

Basis of Presentation and Nature of Business	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Nature of Business	Basis of Presentation FGL Holdings (the “Company”), a Cayman Islands exempted company, markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia. F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability, provides a platform for non-affiliated reinsurance business. Front Street Re Cayman Ltd (“FSRC”), an exempted company incorporated in the Cayman Islands with limited liability, has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of the Company and parties to reinsurance transactions. On February 7, 2020, FGL Holdings and Fidelity National Financial, Inc. (NYSE: FNF) (“FNF”) entered into a merger agreement pursuant to which FNF will acquire FGL Holdings for $12.50 per share, representing an equity value of approximately $2.7 billion . Under the terms of the merger agreement, holders of FGL Holdings' ordinary shares (other than FNF and its subsidiaries) may elect to receive either (i) $12.50 per share in cash or (ii) 0.2558 of a share of FNF common stock for each ordinary share of FGL Holdings they own. This is subject to an election and proration mechanism such that the aggregate consideration paid to such holders of FGL Holdings' ordinary shares will consist of approximately 60% cash and 40% FNF common stock. The transaction is expected to close in the second or third quarter of 2020, subject to the satisfaction of customary closing conditions, including the receipt of regulatory clearances and approval by FGL Holdings shareholders. The accompanying unaudited condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X, consisting of normal recurring items considered necessary for a fair statement of the results for the interim periods presented. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. Therefore, the information contained in the Notes to Consolidated Financial Statements included in the Company's 2019 Form 10-K, should be read in connection with the reading of these interim unaudited condensed consolidated financial statements. In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Operating results for the three months ended March 31, 2020 , are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020 . Amounts reclassified out of other comprehensive income are reflected in net investment gains (losses) in the unaudited Condensed Consolidated Statements of Operations. Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.

Significant Accounting Policies

Significant Accounting Policies and Practices	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Significant Accounting Policies and Practices	Adoption of New Accounting Pronouncements Test for Goodwill Impairment In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment , effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update: • the subsequent measurement of goodwill is simplified by the elimination of step 2 from the goodwill impairment test, which required an entity to determine the implied fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination • the entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, not to exceed the total amount of goodwill allocated to that reporting unit • the entity is no longer required to perform a qualitative assessment for any reporting unit with a zero or negative carrying amount The Company adopted this standard on January 1, 2020, and it did not impact its unaudited condensed consolidated financial statements. Fair Value Measurement In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update: • for investments in certain entities that calculate net asset value, investors are required to disclose the timing of liquidation of an investee's assets and the date when restrictions from redemption might lapse if the investee has communicated timing to the entity or announced timing publicly • entities should use the measurement uncertainty disclosure to communicate information about the uncertainty in measurement as of the reporting date • entities must disclose changes in unrealized gains and losses included in other comprehensive income for recurring Level 3 fair value measurements, as well as the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, or other quantitative information in lieu of weighted average if the entity determines such information would be more reasonable and rational • entities are no longer required to disclose the amounts and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements The Company adopted this standard on January 1, 2020, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Consolidation In October 2018, the FASB issued ASU 2018-17, Consolidation (Topic 810), Targeted Improvements to Related Party Guidance for Variable Interest Entities, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update, entities must consider indirect interests held through related parties under common control on a proportional basis to determine whether a decision-making fee is a variable interest. The Company adopted this standard on January 1, 2020, and it did not impact its unaudited condensed consolidated financial statements. New Credit Loss Standard In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (ASC 326), Measurement of Credit Losses on Financial Instruments , effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Since its release, certain targeted improvements and transition relief amendments have been made to ASU 2016-13 and have been published in ASU 2018-19, ASU 2019-04, ASU 2019-05 and ASU 2019-11. Collectively, these ASUs changed the accounting for impairment of most financial assets and certain other instruments in the following ways: • financial assets (or a group of financial assets) measured at amortized cost are required to be presented at the net amount expected to be collected, with an allowance for expected credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount • credit losses relating to available-for-sale ("AFS") fixed maturity securities generally are recorded through an allowance for expected credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for expected credit losses for AFS fixed maturity securities is limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value • the income statement reflects the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount The Company adopted this standard effective January 1, 2020 using a modified-retrospective approach, as required. As a result of adoption, the Company recorded a cumulative-effect adjustment, which decreased retained earnings by $24 , net of tax. We recorded offsetting increases to the allowance for expected credit losses for mortgage loans and reinsurance recoverables and a decrease for deferred tax impacts. Refer to Note 4. "Investments" and Note 13. "Reinsurance" for additional information. Future Accounting Pronouncements Long-Duration Insurance Contracts In August 2018, the FASB issued ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts , effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Under this update: • assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations • the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income • market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income • deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts • deferred acquisition costs must be written off for unexpected contract terminations • disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements. Simplifying the Accounting for Income Taxes In December 2019, the FASB issued ASU 2019-12 Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes , effective for the fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update: • accounting for income taxes is simplified by removing certain exceptions, including exceptions related to the incremental approach for intraperiod tax allocation, calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences • the accounting for franchise taxes, transactions that result in a step-up in the tax basis of goodwill and enacted changes in tax laws or rates has been clarified • the consolidated amount of current and deferred tax expense to a legal entity that is not subject to tax in its separate financial statements is not required to be allocated, although the entity may elect to do so

Significant Risks and Uncertain

Significant Risks and Uncertainties	3 Months Ended
	Mar. 31, 2020
Risks and Uncertainties [Abstract]
Significant Risks and Uncertainties	Significant Risks and Uncertainties Best Interest Regulation In March 2018, the United States Fifth Circuit Court of Appeals formally vacated the U. S. Department Labor “Fiduciary Rule” which would have imposed fiduciary duties upon insurance agents selling Individual Retirement Account (IRA) annuities and would have potentially had a material impact on the Company, its products, distribution, and business model. Since then, in June 2019, the U.S. Securities and Exchange Commission (SEC) adopted Regulation Best Interest imposing new sales practice standards on securities brokers, which does not directly impact the Company or its distributors, but gives impetus for the National Association of Insurance Commissioners (NAIC) and individual states to consider best interest proposals for insurance sales. The NAIC adopted an amended Suitability in Annuity Transactions Model Regulation in February 2020 incorporating a requirement that agents act in the best interest of consumers without putting their own financial interests or insurer’s interests ahead of consumer interests. It is expected individual states may soon begin to consider and adopt the NAIC model regulation. FGL NY Insurance already modified certain new business processes in response to the New York Department of Financial Services (NYDFS) best interest rule despite relatively low sales in New York. Management is following a legal challenge to nullify the NYDFS rule and will continue to monitor action by other state or federal agencies to implement sales practice rules affecting insurance agents selling fixed insurance or annuity products. Use of Estimates and Assumptions The preparation of the Company's unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used. Concentrations of Financial Instruments As of March 31, 2020 and December 31, 2019 , the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the Banking industry with a fair value of $2,216 or 9% and $2,414 or 9% , respectively, of the invested assets portfolio and an amortized cost of $2,270 and $2,325 , respectively. As of March 31, 2020 , the Company’s holdings in this industry include investments in 101 different issuers with the top ten investments accounting for 38% of the total holdings in this industry. As of March 31, 2020 the Company had eighty-six investments in issuers that exceeded 10% of shareholders' equity; the top ten being HP Enterprise Co., HSBC Holdings, Metropolitan Transportation Authority (NY), Verizon Communications Inc., Prudential Financial Inc, AT&T Inc, Nationwide Mutual Insurance Company, CVI CVF III Master Fund II LL, Electricite De France and Blackstone Div Alt Issr. As of December 31, 2019 , the Company had no investments in issuers that exceeded 10% of shareholders' equity. The increase in investments that exceed 10% of shareholders' equity is due to the significant increase in unrealized losses on fixed maturity securities investments during the three months ended March 31, 2020 and the resulting decrease in shareholders' equity. The Company's largest concentration in any single issuer was HP Enterprise Co with a total fair value of $123 or 1% of the invested assets portfolio as of March 31, 2020 , and HSBC Holdings , with a total fair value of $132 or 1% of the invested assets portfolio as of December 31, 2019 . Concentrations of Financial and Capital Markets Risk The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company’s exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will increase the net unrealized loss position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. The Company attempts to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset backed securities. Management believes this risk is also mitigated to some extent by surrender charge protection provided by the Company’s products. The Company expects to continue to face these challenges and uncertainties that could adversely affect its results of operations and financial condition. The Company is closely monitoring developments related to the COVID-19 pandemic to assess its impact on our business. While still evolving, the COVID-19 pandemic has caused significant economic and financial turmoil in the U.S. and around the world, and has fueled concerns that it will lead to a global recession. These conditions may continue or worsen in the near term. At this time, it is not possible to estimate how long it will take to halt the spread of the virus or the longer term-effects the COVID-19 pandemic could have on our business. Increased economic uncertainty and increased unemployment resulting from the economic impacts of the spread of COVID-19 may result in policyholders seeking sources of liquidity and withdrawing at rates greater than we previously expected. If policyholder lapse and surrender rates significantly exceed our expectations, it could have a material adverse effect on our business, financial condition, results of operations, liquidity and cash flows. Such events or conditions could also have an adverse effect on our sales of new policies. The Company is monitoring the impact of COVID-19 on the Company’s investment portfolio and the potential for ratings changes caused by the sudden slowdown of economic activity. The extent to which the COVID-19 pandemic impacts our business, results of operations, financial condition, liquidity or prospects will depend on future developments which are highly uncertain and cannot be predicted. Concentration of Reinsurance Risk The Company has a significant concentration of reinsurance risk with third party reinsurers, Wilton Reassurance Company (“Wilton Re”) and Kubera Insurance (SAC) Ltd. ("Kubera"), that could have a material impact on the Company’s financial position in the event that either Wilton Re or Kubera fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly-owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA issuer credit rating from Standard & Poor's Ratings Services ("S&P") as of March 31, 2020 . Kubera is not rated, however, management has attempted to mitigate the risk of non-performance through the funds withheld arrangement. As of March 31, 2020 , the net amount recoverable from Wilton Re was $1,507 and the net amount recoverable from Kubera was $835 . The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar activities and economic characteristics of reinsurers to attempt to reduce the risk of default by such reinsurers. The Company believes that all amounts due from Wilton Re and Kubera for periodic treaty settlements are collectible as of March 31, 2020 . On March 6, 2019, Scottish Re (U.S.), Inc. (“SRUS”), a Delaware domestic life and health reinsurer of FGL Insurance, was ordered into receivership for purposes of rehabilitation. As of March 31, 2020 , the net amount recoverable from SRUS was $48 . The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business. On July 9, 2019, Pavonia Life Insurance Company of Michigan ("Pavonia"), a Michigan domiciled life, accident, and health insurance company, was placed into rehabilitation. While the court order indicated that Pavonia had a stable financial condition and lack of non-insurance affiliated investments, the Director of the Michigan Department of Insurance and Financial Services ("MDIFS") has concerns relating to Pavonia's parent company. To insulate Pavonia from its parent until a pending acquisition transaction could be consummated, MDIFS placed Pavonia under supervision and rehabilitation. As of March 31, 2020 , the net amount recoverable from Pavonia was $86 . The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

Investments

Investments	3 Months Ended
	Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Investments	1.25 1.00 - 1.25 March 31, 2020 LTV Ratios: Less than 50% $ 278 $ 6 $ 284 58 % $ 295 58 % 50% to 60% 159 — 159 33 % 166 33 % 60% to 75% 44 — 44 9 % 46 9 % Commercial mortgage loans $ 481 $ 6 $ 487 100 % $ 507 100 % December 31, 2019 LTV Ratios: Less than 50% $ 346 $ 6 $ 352 83 % $ 363 83 % 50% to 60% 70 — 70 17 % 72 17 % Commercial mortgage loans $ 416 $ 6 $ 422 100 % $ 435 100 % The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At March 31, 2020 and December 31, 2019 , the Company had no CMLs that were delinquent in principal or interest payments. Allowance for Expected Credit Loss The Company estimates expected credit losses for their commercial loan portfolio using a probability of default/loss given default model. Significant inputs to this model include the loans current performance, underlying collateral type, location, contractual life, LTV, and DSC. The model projects losses using a 2 year reasonable and supportable forecast and then reverts over a 3 year period to market-wide historical loss experience. Changes in the Company’s allowance for expected credit losses on commercial mortgage loans are recognized in “Net investment gains (losses)” in the accompanying unaudited Condensed Consolidated Statements of Operations. An allowance for expected credit loss is not measured on accrued interest income for commercial mortgage loans as the Company has a process to write-off interest on loans that enter in to non-accrual status (over 90 days past due). Prior to adoption of ASC 326 effective January 1, 2020, the Company established a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. The Company believed that the LTV ratio was an indicator of the principal recovery risk for loans that default. A higher LTV ratio resulted in a higher allowance. The Company believed that the DSC ratio was an indicator of default risk on loans. A higher DSC ratio resulted in a lower allowance. Residential Mortgage Loans Residential mortgage loans ("RMLs") represented approximately 5% and 3% of the Company’s total investments as of March 31, 2020 and December 31, 2019 . The Company's residential mortgage loans are closed end, amortizing loans and 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables: March 31, 2020 US State: Unpaid Principal Balance % of Total California $ 236 19 % Florida 206 16 % New Jersey 122 10 % All Other States (a) 704 56 % Total mortgage loans $ 1,268 100 % (a) The individual concentration of each state is less than 9% as of March 31, 2020 . December 31, 2019 US State: Unpaid Principal Balance % of Total California $ 167 20 % Florida 141 17 % New Jersey 76 9 % All Other States (a) 447 54 % Total mortgage loans $ 831 100 % (a) The individual concentration of each state is less than 9% as of December 31, 2019 . Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at March 31, 2020 and December 31, 2019 , respectively, was as follows: March 31, 2020 December 31, 2019 Performance indicators: Carrying Value % of Total Carrying Value % of Total Performing $ 1,282 100 % $ 843 100 % Non-performing 11 — % 2 — % Total residential mortgage loans, gross of valuation allowance $ 1,293 100 % 845 100 % Allowance for expected credit loss (11 ) — % — — % Total residential mortgage loans $ 1,282 100 % $ 845 100 % Loans segregated by risk rating exposure as at March 31, 2020 , was as follows: March 31, 2020 Term Loans Amortized Cost by Origination Year 2020 2019 2018 2017 2016 Prior Total Residential mortgages Current (less than 30 days past due) 304 671 73 48 63 3 1,162 30-89 days past due 12 100 6 — 2 — 120 Over 90 days past due — 9 2 — — — 11 Total residential mortgages 316 780 81 48 65 3 1,293 Commercial mortgages Current (less than 30 days past due) 68 — 6 — 11 403 488 30-89 days past due — — — — — — — Over 90 days past due — — — — — — — Total commercial mortgage 68 — 6 — 11 403 488 March 31, 2020 Term Loans Amortized Cost by Origination Year 2020 2019 2018 2017 2016 Prior Total Commercial mortgages LTV Less than 50% — — 6 — — 278 284 50% to 60% 34 — — — — 125 159 60% to 75% 34 — — — 11 — 45 Total commercial mortgages 68 — 6 — 11 403 488 Commercial mortgages DSCR Greater than 1.25x 68 — 6 — 11 397 482 1.00x - 1.25x — — — — — 6 6 Less than 1.00x — — — — — — — Total commercial mortgages 68 — 6 — 11 403 488 Allowance for Expected Credit Loss The Company estimates expected credit losses for their residential mortgage loan portfolio using a probability of default/loss given default model. Significant inputs to this model include the loans current performance, underlying collateral type, location, contractual life, LTV, and Debt to Income or FICO. The model projects losses using a 2 year reasonable and supportable forecast and then reverts over a 3 year period to market-wide historical loss experience. Changes in the Company’s allowance for expected credit losses on commercial mortgage loans are recognized in “Net investment gains (losses)” in the accompanying unaudited Condensed Consolidated Statements of Operations. Residential Mortgage Loans Commercial Mortgage Loans Total Balance as at January 1, 2020 7 1 8 (Reversal of) provision for loan losses 4 — 4 Balance as at March 31, 2020 11 1 12 An allowance for expected credit loss is not measured on accrued interest income for commercial mortgage loans as the Company has a process to write-off interest on loans that enter in to non-accrual status (over 90 days past due). March 31, 2020 Residential Mortgage Loans 11 Commercial Mortgage Loans — Total loans that are 90 days or more past due and still accruing 11 Net Investment Income The major sources of “Net investment income” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended March 31, 2020 March 31, 2019 Fixed maturity securities, available-for-sale $ 258 $ 265 Equity securities 14 21 Mortgage loans 21 7 Invested cash and short-term investments 4 3 Funds withheld 22 8 Limited partnerships 25 8 Other investments 6 5 Gross investment income 350 317 Investment expense (33 ) (28 ) Net investment income $ 317 $ 289 Net Investment Gains (Losses) Details underlying “Net investment gains (losses)” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended March 31, 2020 March 31, 2019 Net realized gains (losses) on fixed maturity available-for-sale securities $ 21 $ (3 ) Net realized/unrealized gains (losses) on equity securities (135 ) 78 Realized gains (losses) on other invested assets (7 ) 1 Change in allowance for expected credit losses (48 ) — Derivatives, embedded derivatives and financial instruments under fair value option: Realized gains (losses) on certain derivative instruments 38 (26 ) Unrealized gains (losses) on certain derivative instruments (396 ) 190 Change in fair value of reinsurance related embedded derivatives and change in fair value of funds withheld for reinsurance receivables, held at fair value (a) (161 ) (3 ) Change in fair value of other derivatives and embedded derivatives (4 ) 3 Realized gains (losses) on derivatives and embedded derivatives (523 ) 164 Net investment gains (losses) $ (692 ) $ 240 (a) Change in fair value of reinsurance related embedded derivatives is due to F&G Re and FSRC unaffiliated third party business under the fair value option election, and activity related to the FGL Insurance and Kubera reinsurance treaty. The Company's adoption of ASU 2016-13 had a $(48) impact on pre-tax net income (loss), or $(0.23) per common share, for the three months ended March 31, 2020. The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows: Three months ended March 31, 2020 March 31, 2019 Proceeds $ 462 $ 474 Gross gains 16 5 Gross losses (3 ) (10 ) Unconsolidated Variable Interest Entities FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements, and one investment in a VIE that is consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. VIE’s are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While FGL Insurance participates in the benefits from VIEs in which it invests, but does not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under common control with FGL Insurance. It is for this reason that FGL Insurance is not considered the primary beneficiary for the VIE investments that are not consolidated. The Company has concluded it is the primary beneficiary of BIS Co-Invest Fund II L.P (“Co-Invest II”). The primary beneficiary conclusion was drawn given the fact that substantially all of Co-Invest II’s activities are conducted on behalf of the Company, its sole investor and limited partner. As the Company is considered the primary beneficiary, Co-Invest II is consolidated within the Company’s financial statements. As of March 31, 2020 , the Company has $52 of net assets recorded related to Co-Invest II. The Company previously executed a commitment of $83 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power. The Company had fully funded this commitment as of January 31, 2020. During the quarter ended March 31, 2020 , the BDC was listed on the NASDAQ. The Company invests in various limited partnerships as a passive investor. These investments are in credit funds with a bias towards current income, real assets, or private equity. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s unaudited Condensed Consolidated Balance Sheets. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's unaudited Condensed Consolidated Balance Sheets in addition to any required unfunded commitments. As of March 31, 2020 , the Company's maximum exposure to loss was $1,066 in recorded carrying value and $1,252" id="sjs-B4">Investments The Company’s fixed maturity securities investments have been designated as available-for-sale and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included in AOCI, net of associated adjustments for deferred acquisition costs ("DAC"), value of business acquired ("VOBA"), deferred sales inducements ("DSI"), unearned revenue ("UREV"), and deferred income taxes. The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income (loss). The Company’s consolidated investments at March 31, 2020 and December 31, 2019 are summarized as follows: March 31, 2020 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 5,785 $ (17 ) $ 26 $ (849 ) $ 4,945 $ 4,945 Commercial mortgage-backed securities 2,848 — 16 (383 ) 2,481 2,481 Corporates 10,898 (21 ) 366 (792 ) 10,451 10,451 Hybrids 976 — 5 (90 ) 891 891 Municipals 1,270 — 63 (15 ) 1,318 1,318 Residential mortgage-backed securities 884 (6 ) 17 (25 ) 870 870 U.S. Government 40 — 3 — 43 43 Foreign Governments 135 — 7 (1 ) 141 141 Total available-for-sale securities 22,836 (44 ) 503 (2,155 ) 21,140 21,140 Equity securities 1,052 1 (138 ) 915 915 Derivative investments 380 13 (205 ) 188 188 Commercial mortgage loans 488 (1 ) — — 507 487 Residential mortgage loans 1,293 (11 ) — — 1,297 1,282 Other invested assets 1,497 — (6 ) 1,479 1,491 Total investments $ 27,546 $ (56 ) $ 517 $ (2,504 ) $ 25,526 $ 25,503 December 31, 2019 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 5,720 $ 51 $ (77 ) $ 5,694 $ 5,694 Commercial mortgage-backed securities 2,788 140 (6 ) 2,922 2,922 Corporates 11,051 618 (72 ) 11,597 11,597 Hybrids 983 48 (4 ) 1,027 1,027 Municipals 1,284 64 (5 ) 1,343 1,343 Residential mortgage-backed securities 917 40 (3 ) 954 954 U.S. Government 33 1 — 34 34 Foreign Governments 138 17 — 155 155 Total available-for-sale securities 22,914 979 (167 ) 23,726 23,726 Equity securities 1,069 19 (17 ) 1,071 1,071 Derivative investments 336 261 (10 ) 587 587 Commercial mortgage loans 422 — — 435 422 Residential mortgage loans 845 — — 848 845 Other invested assets 1,306 — (3 ) 1,288 1,303 Total investments $ 26,892 $ 1,259 $ (197 ) $ 27,955 $ 27,954 Securities held on deposit with various state regulatory authorities had a fair value of $16,337 and $17,591 at March 31, 2020 and December 31, 2019 , respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the legal reserve. At March 31, 2020 and December 31, 2019 , the Company held no material investments that were non-income producing for a period greater than twelve months. In accordance with the Company's FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $1,472 and $1,472 at March 31, 2020 and December 31, 2019 , respectively. The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations. March 31, 2020 Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 84 $ 80 Due after one year through five years 915 870 Due after five years through ten years 1,942 1,872 Due after ten years 10,378 10,022 Subtotal 13,319 12,844 Other securities which provide for periodic payments: Asset-backed securities 5,785 4,945 Commercial mortgage-backed securities 2,848 2,481 Residential mortgage-backed securities 884 870 Subtotal 9,517 8,296 Total fixed maturity available-for-sale securities $ 22,836 $ 21,140 Allowance for Expected Credit Loss Following the adoption of ASU 2016-13 and the related targeted improvements and transition relief amendments (see Note 2. Significant Accounting Policies and Practices for further details) effective January 1, 2020, the Company regularly reviews AFS securities for declines in fair value that it determines to be credit related. For its fixed maturity AFS securities, the Company generally considers the following in determining whether its unrealized losses are credit related, and if so, the magnitude of the credit loss: • The extent to which the fair value is less than the amortized cost basis; • The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening); • The financial condition of and near-term prospects of the issuer (including issuer's current credit rating and the probability of full recovery of principal based upon the issuer's financial strength); • Current delinquencies and nonperforming assets of underlying collateral; • Expected future default rates; • Collateral value by vintage, geographic region, industry concentration or property type; • Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and • Contractual and regulatory cash obligations and the issuer's plans to meet such obligations. The Company recognizes an allowance for expected credit losses on fixed maturity securities in an unrealized loss position when it is determined, using the factors discussed above, a component of the unrealized loss is related to credit. The Company measures the credit loss using a discounted cash flow model that utilizes the single best estimate cash flow and the recognized credit loss is limited to the total unrealized loss on the security (i.e. the fair value floor). Cash flows are discounted using the implicit yield of bonds at their time of purchase and the current book yield for asset and mortgage backed securities as well as variable rate securities. The Company recognizes the expected credit losses in "Net investment gains (losses)" in the unaudited Condensed Consolidated Statements of Operations, with an offset for the amount of non-credit impairments recognized in AOCI. We do not measure a credit loss allowance on accrued investment income because we write-off accrued interest through to net investment income (loss) when collectability concerns arise. The Company considers the following in determining whether write-offs of a security’s amortized cost is necessary: • The Company believes amounts related to securities have become uncollectible; or • The Company intends to sell a security; or • It is more likely than not that the Company will be required to sell a security prior to recovery. If the Company intends to sell a fixed maturity AFS security or it is more likely than not the Company will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, the Company will write down the security to current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying unaudited Condensed Consolidated Statements of Operations. If the Company does not intend to sell a fixed maturity security or it is more likely than not the Company will not be required to sell a fixed maturity security before recovery of its amortized cost basis but believes amounts related to a security are uncollectible (generally based on proximity to expected credit loss), an impairment is deemed to have occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge, net of any amount previously recognized as an allowance for expected credit loss, to “Net investment gains (losses)” in the accompanying unaudited Condensed Consolidated Statements of Operations. The remainder of unrealized loss is held in AOCI. The activity in the allowance for expected credit losses of available-for-sale securities aggregated by investment category were as follows: For the quarter ended March 31, 2020 Additions Reductions Balance at Beginning of Period For credit losses on securities for which losses were not previously recorded For initial credit losses on purchased securities accounted for as PCD financial assets (a) Additions (reductions) in allowance recorded on previously impaired securities For securities sold during the period For securities intended/required to be sold prior to recovery of amortized cost basis Writeoffs charged against the allowance Balance at End of Period Available-for-sale securities Asset-backed securities — (17 ) — — — — — (17 ) Commercial mortgage-backed securities — — — — — — — — Corporates — (22 ) — — — — 1 (21 ) Hybrids — — — — — — — — Municipals — — — — — — — — Residential mortgage-backed securities — (6 ) — — — — — (6 ) US Government — — — — — — — — Foreign Government — — — — — — — — Total available-for-sale securities $ — $ (45 ) $ — $ — $ — $ — $ 1 $ (44 ) (a) Purchased credit deteriorated financial assets ("PCD") The fair value and gross unrealized losses of available-for-sale securities, excluding securities in an unrealized losses position with an allowance for expected credit loss, aggregated by investment category and duration of fair value below amortized cost as of March 31, 2020, were as follows: March 31, 2020 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 2,872 $ (518 ) $ 1,322 $ (325 ) $ 4,194 $ (843 ) Commercial mortgage-backed securities 2,073 (378 ) 13 (5 ) 2,086 (383 ) Corporates 4,691 (644 ) 239 (144 ) 4,930 (788 ) Hybrids 669 (79 ) 31 (11 ) 700 (90 ) Municipals 323 (12 ) 51 (3 ) 374 (15 ) Residential mortgage-backed securities 146 (13 ) 65 (6 ) 211 (19 ) Foreign Government 33 (1 ) — — 33 (1 ) Total available-for-sale securities $ 10,807 $ (1,645 ) $ 1,721 $ (494 ) $ 12,528 $ (2,139 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,365 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 294 Total number of available-for-sale securities in an unrealized loss position 1,659 The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost as of December 31, 2019, were as follows: December 31, 2019 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 719 $ (12 ) $ 2,453 $ (65 ) $ 3,172 $ (77 ) Commercial mortgage-backed securities 232 (4 ) 16 (2 ) 248 (6 ) Corporates 1,030 (25 ) 804 (47 ) 1,834 (72 ) Hybrids 23 (1 ) 60 (3 ) 83 (4 ) Municipals 123 (2 ) 60 (3 ) 183 (5 ) Residential mortgage-backed securities 41 — 107 (3 ) 148 (3 ) U.S. Government 6 — — — 6 — Total available-for-sale securities $ 2,174 $ (44 ) $ 3,500 $ (123 ) $ 5,674 $ (167 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 290 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 446 Total number of available-for-sale securities in an unrealized loss position 736 The Company determined the significant increase in unrealized losses as of March 31, 2020 was caused by the significant widening of spreads in fixed income markets in response to the economic uncertainty created by the COVID-19 pandemic. These widening spreads were in most cases driven by market illiquidity and perceived increases in credit risk. For securities in an unrealized loss position as of March 31, 2020 and an expected credit loss was not determined, the Company believes that the unrealized loss is being driven by interest rate declines or near-term illiquidity and uncertainty of the impact of COVID-19 on the economy as opposed to issuer specific credit concerns. Specific to asset-backed and mortgage-backed securities for which an expected credit loss was not determined, the effect of any increased expectations of underlying collateral defaults have not risen to the level of impacting the tranches of those securities held by the Company. Other-Than-Temporary-Impairment Prior to the adoption of ASC 326 in 2020, the Company evaluated and identified securities for other-than-temporary impairment. For factors considered in evaluating whether a decline in value was other-than-temporary, please refer to “Note 2. Significant Accounting Policies and Practices" to the Company’s 2019 Form 10-K. The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the three months ended March 31, 2019 : Three months ended March 31, 2019 Credit impairment losses in operations $ (2 ) Change-of-intent losses in operations — Amortized cost 1 Fair value 1 Non-credit losses in other comprehensive income for investments which experienced OTTI — Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows: Three months ended March 31, 2019 Corporates $ (2 ) Total $ (2 ) The following table provides a reconciliation of the beginning and ending balances within AOCI of the non-credit loss portion of impairment on fixed maturity available-for-sale securities held by the Company for the three months ended March 31, 2019 : Three months ended March 31, 2019 Beginning balance $ — Increases attributable to credit losses on securities: OTTI was previously recognized — OTTI was not previously recognized — Ending balance $ — Mortgage Loans The Company's mortgage loans are collateralized by commercial and residential properties. Commercial Mortgage Loans Commercial mortgage loans ("CMLs") represented approximately 2% of the Company’s total investments as of March 31, 2020 and December 31, 2019 . The Company primarily invests in mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to attempt to reduce concentration risk. The Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: March 31, 2020 December 31, 2019 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: Hotel $ 21 4 % $ 21 5 % Industrial - General 37 8 % 37 9 % Industrial - Warehouse 20 4 % 20 4 % Multifamily 121 25 % 54 13 % Office 142 29 % 143 34 % Retail 147 30 % 147 35 % Total commercial mortgage loans, gross of valuation allowance $ 488 100 % $ 422 100 % Allowance for expected credit loss (1 ) — Total commercial mortgage loans $ 487 $ 422 U.S. Region: East North Central $ 64 13 % $ 64 15 % East South Central 53 11 % 19 5 % Middle Atlantic 77 16 % 77 18 % Mountain 51 10 % 51 12 % New England 4 1 % 4 1 % Pacific 112 23 % 113 27 % South Atlantic 55 11 % 56 13 % West North Central 13 3 % 13 3 % West South Central 59 12 % 25 6 % Total commercial mortgage loans, gross of valuation allowance $ 488 100 % $ 422 100 % Allowance for expected credit loss (1 ) — Total commercial mortgage loans $ 487 $ 422 All of the Company's investments in CMLs had a loan-to-value ("LTV") ratio of less than 75% at March 31, 2020 and December 31, 2019 , as measured at inception of the loans unless otherwise updated. LTV and debt service coverage ("DSC") ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation. The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at March 31, 2020 and December 31, 2019 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 March 31, 2020 LTV Ratios: Less than 50% $ 278 $ 6 $ 284 58 % $ 295 58 % 50% to 60% 159 — 159 33 % 166 33 % 60% to 75% 44 — 44 9 % 46 9 % Commercial mortgage loans $ 481 $ 6 $ 487 100 % $ 507 100 % December 31, 2019 LTV Ratios: Less than 50% $ 346 $ 6 $ 352 83 % $ 363 83 % 50% to 60% 70 — 70 17 % 72 17 % Commercial mortgage loans $ 416 $ 6 $ 422 100 % $ 435 100 % The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At March 31, 2020 and December 31, 2019 , the Company had no CMLs that were delinquent in principal or interest payments. Allowance for Expected Credit Loss The Company estimates expected credit losses for their commercial loan portfolio using a probability of default/loss given default model. Significant inputs to this model include the loans current performance, underlying collateral type, location, contractual life, LTV, and DSC. The model projects losses using a 2 year reasonable and supportable forecast and then reverts over a 3 year period to market-wide historical loss experience. Changes in the Company’s allowance for expected credit losses on commercial mortgage loans are recognized in “Net investment gains (losses)” in the accompanying unaudited Condensed Consolidated Statements of Operations. An allowance for expected credit loss is not measured on accrued interest income for commercial mortgage loans as the Company has a process to write-off interest on loans that enter in to non-accrual status (over 90 days past due). Prior to adoption of ASC 326 effective January 1, 2020, the Company established a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. The Company believed that the LTV ratio was an indicator of the principal recovery risk for loans that default. A higher LTV ratio resulted in a higher allowance. The Company believed that the DSC ratio was an indicator of default risk on loans. A higher DSC ratio resulted in a lower allowance. Residential Mortgage Loans Residential mortgage loans ("RMLs") represented approximately 5% and 3% of the Company’s total investments as of March 31, 2020 and December 31, 2019 . The Company's residential mortgage loans are closed end, amortizing loans and 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables: March 31, 2020 US State: Unpaid Principal Balance % of Total California $ 236 19 % Florida 206 16 % New Jersey 122 10 % All Other States (a) 704 56 % Total mortgage loans $ 1,268 100 % (a) The individual concentration of each state is less than 9% as of March 31, 2020 . December 31, 2019 US State: Unpaid Principal Balance % of Total California $ 167 20 % Florida 141 17 % New Jersey 76 9 % All Other States (a) 447 54 % Total mortgage loans $ 831 100 % (a) The individual concentration of each state is less than 9% as of December 31, 2019 . Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at March 31, 2020 and December 31, 2019 , respectively, was as follows: March 31, 2020 December 31, 2019 Performance indicators: Carrying Value % of Total Carrying Value % of Total Performing $ 1,282 100 % $ 843 100 % Non-performing 11 — % 2 — % Total residential mortgage loans, gross of valuation allowance $ 1,293 100 % 845 100 % Allowance for expected credit loss (11 ) — % — — % Total residential mortgage loans $ 1,282 100 % $ 845 100 % Loans segregated by risk rating exposure as at March 31, 2020 , was as follows: March 31, 2020 Term Loans Amortized Cost by Origination Year 2020 2019 2018 2017 2016 Prior Total Residential mortgages Current (less than 30 days past due) 304 671 73 48 63 3 1,162 30-89 days past due 12 100 6 — 2 — 120 Over 90 days past due — 9 2 — — — 11 Total residential mortgages 316 780 81 48 65 3 1,293 Commercial mortgages Current (less than 30 days past due) 68 — 6 — 11 403 488 30-89 days past due — — — — — — — Over 90 days past due — — — — — — — Total commercial mortgage 68 — 6 — 11 403 488 March 31, 2020 Term Loans Amortized Cost by Origination Year 2020 2019 2018 2017 2016 Prior Total Commercial mortgages LTV Less than 50% — — 6 — — 278 284 50% to 60% 34 — — — — 125 159 60% to 75% 34 — — — 11 — 45 Total commercial mortgages 68 — 6 — 11 403 488 Commercial mortgages DSCR Greater than 1.25x 68 — 6 — 11 397 482 1.00x - 1.25x — — — — — 6 6 Less than 1.00x — — — — — — — Total commercial mortgages 68 — 6 — 11 403 488 Allowance for Expected Credit Loss The Company estimates expected credit losses for their residential mortgage loan portfolio using a probability of default/loss given default model. Significant inputs to this model include the loans current performance, underlying collateral type, location, contractual life, LTV, and Debt to Income or FICO. The model projects losses using a 2 year reasonable and supportable forecast and then reverts over a 3 year period to market-wide historical loss experience. Changes in the Company’s allowance for expected credit losses on commercial mortgage loans are recognized in “Net investment gains (losses)” in the accompanying unaudited Condensed Consolidated Statements of Operations. Residential Mortgage Loans Commercial Mortgage Loans Total Balance as at January 1, 2020 7 1 8 (Reversal of) provision for loan losses 4 — 4 Balance as at March 31, 2020 11 1 12 An allowance for expected credit loss is not measured on accrued interest income for commercial mortgage loans as the Company has a process to write-off interest on loans that enter in to non-accrual status (over 90 days past due). March 31, 2020 Residential Mortgage Loans 11 Commercial Mortgage Loans — Total loans that are 90 days or more past due and still accruing 11 Net Investment Income The major sources of “Net investment income” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended March 31, 2020 March 31, 2019 Fixed maturity securities, available-for-sale $ 258 $ 265 Equity securities 14 21 Mortgage loans 21 7 Invested cash and short-term investments 4 3 Funds withheld 22 8 Limited partnerships 25 8 Other investments 6 5 Gross investment income 350 317 Investment expense (33 ) (28 ) Net investment income $ 317 $ 289 Net Investment Gains (Losses) Details underlying “Net investment gains (losses)” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended March 31, 2020 March 31, 2019 Net realized gains (losses) on fixed maturity available-for-sale securities $ 21 $ (3 ) Net realized/unrealized gains (losses) on equity securities (135 ) 78 Realized gains (losses) on other invested assets (7 ) 1 Change in allowance for expected credit losses (48 ) — Derivatives, embedded derivatives and financial instruments under fair value option: Realized gains (losses) on certain derivative instruments 38 (26 ) Unrealized gains (losses) on certain derivative instruments (396 ) 190 Change in fair value of reinsurance related embedded derivatives and change in fair value of funds withheld for reinsurance receivables, held at fair value (a) (161 ) (3 ) Change in fair value of other derivatives and embedded derivatives (4 ) 3 Realized gains (losses) on derivatives and embedded derivatives (523 ) 164 Net investment gains (losses) $ (692 ) $ 240 (a) Change in fair value of reinsurance related embedded derivatives is due to F&G Re and FSRC unaffiliated third party business under the fair value option election, and activity related to the FGL Insurance and Kubera reinsurance treaty. The Company's adoption of ASU 2016-13 had a $(48) impact on pre-tax net income (loss), or $(0.23) per common share, for the three months ended March 31, 2020. The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows: Three months ended March 31, 2020 March 31, 2019 Proceeds $ 462 $ 474 Gross gains 16 5 Gross losses (3 ) (10 ) Unconsolidated Variable Interest Entities FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements, and one investment in a VIE that is consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. VIE’s are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While FGL Insurance participates in the benefits from VIEs in which it invests, but does not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under common control with FGL Insurance. It is for this reason that FGL Insurance is not considered the primary beneficiary for the VIE investments that are not consolidated. The Company has concluded it is the primary beneficiary of BIS Co-Invest Fund II L.P (“Co-Invest II”). The primary beneficiary conclusion was drawn given the fact that substantially all of Co-Invest II’s activities are conducted on behalf of the Company, its sole investor and limited partner. As the Company is considered the primary beneficiary, Co-Invest II is consolidated within the Company’s financial statements. As of March 31, 2020 , the Company has $52 of net assets recorded related to Co-Invest II. The Company previously executed a commitment of $83 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power. The Company had fully funded this commitment as of January 31, 2020. During the quarter ended March 31, 2020 , the BDC was listed on the NASDAQ. The Company invests in various limited partnerships as a passive investor. These investments are in credit funds with a bias towards current income, real assets, or private equity. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s unaudited Condensed Consolidated Balance Sheets. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's unaudited Condensed Consolidated Balance Sheets in addition to any required unfunded commitments. As of March 31, 2020 , the Company's maximum exposure to loss was $1,066 in recorded carrying value and $1,252

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows: March 31, 2020 December 31, 2019 Assets: Derivative investments: Call options $ 188 $ 587 Other Invested Assets: Other embedded derivatives 17 21 Funds withheld: Call options 1 3 $ 206 $ 611 Liabilities: Contractholder funds: FIA embedded derivative $ 3,303 $ 3,235 Other liabilities: Futures contracts 2 — Reinsurance related embedded derivative (18 ) 33 Preferred shares reimbursement feature embedded derivative 37 16 $ 3,324 $ 3,284 The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows: Three months ended March 31, 2020 March 31, 2019 Net investment gains (losses): Call options $ (360 ) $ 154 Futures contracts — 8 Foreign currency forward 2 2 Other derivatives and embedded derivatives (4 ) 3 Reinsurance related embedded derivatives (161 ) (3 ) Total net investment gains (losses) $ (523 ) $ 164 Benefits and other changes in policy reserves: FIA embedded derivatives $ 68 $ 244 Acquisition and operating expenses, net of deferrals: Preferred shares reimbursement feature embedded derivative $ 21 $ (2 ) Additional Disclosures Other Derivatives and Embedded Derivatives The Company holds a fund-linked note issued by Nomura International Funding Pte. Ltd with a face value of $35 . The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund"), which was based on the actual return of the fund. At March 31, 2020 , the fair value of the fund-linked note and embedded derivative were $29 and $17 , respectively. At December 31, 2019 , the fair value of the fund-linked note and embedded derivative were $29 and $21 , respectively. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale". Fixed Index Annuity ("FIA") Embedded Derivative and Call Options and Futures The Company has FIA Contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under GAAP. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in the accompanying unaudited Condensed Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in the unaudited Condensed Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments". The Company purchases derivatives consisting of a combination of call options and futures contracts on the applicable market indices to fund the index credits due to FIA contractholders. The call options are one , two , three , and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the index policies, the index used to compute the interest credit is reset and the Company purchases new one , two , three , or five year call options to fund the next index credit. The Company manages the cost of these purchases through the terms of its FIA contracts, which permit the Company to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA embedded derivative related to index performance through the current credit period. The call options and futures contracts are marked to fair value with the change in fair value included as a component of “Net investment gains (losses).” The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument term or upon early termination and the changes in fair value of open positions. Other market exposures are hedged periodically depending on market conditions and the Company’s risk tolerance. The Company’s FIA hedging strategy economically hedges the equity returns and exposes the Company to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. The Company uses a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. The Company intends to continue to adjust the hedging strategy as market conditions and the Company’s risk tolerance change. Credit Risk The Company is exposed to credit loss in the event of non-performance by its counterparties on the call options and reflects assumptions regarding this non-performance risk in the fair value of the call options. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table: March 31, 2020 Counterparty Credit Rating (Fitch/Moody's/S&P) (a) Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 2,583 $ 7 $ — $ 7 Deutsche Bank BBB/A3/BBB+ 35 2 1 1 Morgan Stanley */A1/A+ 2,162 8 9 — Barclay's Bank A+/A1/A 4,521 115 110 5 Canadian Imperial Bank of Commerce AA/Aa2/A+ 2,727 31 25 6 Wells Fargo A+/A2/A- 2,558 21 26 — Goldman Sachs A/A3/BBB+ 1,112 5 3 2 Total $ 15,698 $ 189 $ 174 $ 21 December 31, 2019 Counterparty Credit Rating Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 2,718 $ 88 $ 43 $ 45 Deutsche Bank BBB/A3/BBB+ 157 7 7 — Morgan Stanley */A1/A+ 2,053 66 65 1 Barclay's Bank A+/A2/A 4,290 211 193 18 Canadian Imperial Bank of Commerce */Aa2/A+ 2,691 106 74 32 Wells Fargo A+/A2/A- 2,165 81 80 1 Goldman Sachs A/A3/BBB+ 1,065 31 27 4 Total $ 15,139 $ 590 $ 489 $ 101 (a) An * represents credit ratings that were not available. Collateral Agreements The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open option contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying option contracts. The Company's current rating doesn't allow any counterparty the right to terminate ISDA agreements. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, this threshold is set to zero. As of March 31, 2020 and December 31, 2019 , counterparties posted $174 and $489 of collateral, respectively, of which $174 and $446 is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the unaudited Condensed Consolidated Balance Sheets . The remaining $0 and $43 of non-cash collateral was held by a third-party custodian and may not be sold or re-pledged, except in the event of default, and, therefore, is not included in the Company's unaudited Condensed Consolidated Balance Sheets at March 31, 2020 and December 31, 2019 , respectively. This collateral generally consists of U.S. treasury bonds and mortgage-backed securities. Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $21 and $101 at March 31, 2020 and December 31, 2019 , respectively. The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes. The Company reinvests derivative cash collateral to reduce the interest cost. Cash collateral is invested in overnight investment sweep products which are included in "Cash and cash equivalents" in the accompanying unaudited Condensed Consolidated Balance Sheets. The Company held 379 and 879 futures contracts at March 31, 2020 and December 31, 2019 , respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the accompanying unaudited Condensed Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $4 and $5 at March 31, 2020 and December 31, 2019 , respectively. Preferred Equity Remarketing Reimbursement Embedded Derivative Liability On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years . From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is held at fair value within “Other liabilities” in the accompanying unaudited Condensed Consolidated Balance Sheets and it is determined using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option. Changes in fair value of this derivative are recognized within “Acquisition and operating expenses, net of deferrals” in the accompanying unaudited Condensed Consolidated Statements of Operations. Reinsurance Related Embedded Derivatives FGL Insurance entered into a reinsurance agreement with Kubera effective December 31, 2018, to cede certain MYGA and deferred annuity statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. This arrangement creates an obligation for FGL Insurance to pay Kubera at a later date, which results in an embedded derivative. This embedded derivative is considered a total return swap with contractual returns that are attributable to the assets and liabilities associated with this reinsurance arrangement. The fair value of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, were passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. The reinsurance related embedded derivative is reported in “Other assets” if in a net gain position, or “Other liabilities”, if in a net loss position, on the unaudited Condensed Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains (losses)” on the unaudited Condensed Consolidated Statements of Operations .

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows: Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date. Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves. Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources. The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows: March 31, 2020 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 776 $ — $ — $ 776 $ 776 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,183 762 4,945 4,945 Commercial mortgage-backed securities — 2,456 25 2,481 2,481 Corporates — 9,252 1,199 10,451 10,451 Hybrids 267 621 3 891 891 Municipals — 1,279 39 1,318 1,318 Residential mortgage-backed securities — 363 507 870 870 U.S. Government 37 6 — 43 43 Foreign Governments — 125 16 141 141 Equity securities 365 549 1 915 915 Derivative investments — 188 — 188 188 Other invested assets — — 40 40 40 Funds withheld for reinsurance receivables, at fair value 289 1,761 — 2,050 2,050 Total financial assets at fair value $ 1,734 $ 20,783 $ 2,592 $ 25,109 $ 25,109 Liabilities Fair value of future policy benefits — — 1,904 1,904 1,904 Derivatives: FIA embedded derivatives, included in contractholder funds — — 3,303 3,303 3,303 Reinsurance related embedded derivative, included in other liabilities — (18 ) — (18 ) (18 ) Derivative instruments - futures contracts 2 — — 2 2 Preferred shares reimbursement feature embedded derivative — — 37 37 37 Total financial liabilities at fair value $ 2 $ (18 ) $ 5,244 $ 5,228 $ 5,228 December 31, 2019 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 969 $ — $ — $ 969 $ 969 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,866 828 5,694 5,694 Commercial mortgage-backed securities — 2,895 27 2,922 2,922 Corporates — 10,305 1,292 11,597 11,597 Hybrids 299 718 10 1,027 1,027 Municipals — 1,301 42 1,343 1,343 Residential mortgage-backed securities — 408 546 954 954 U.S. Government 28 6 — 34 34 Foreign Governments — 137 18 155 155 Equity securities 387 614 1 1,002 1,002 Derivative investments — 587 — 587 587 Other invested assets — — 46 46 46 Funds withheld for reinsurance receivables, at fair value 314 1,856 1 2,171 2,171 Total financial assets at fair value $ 1,997 $ 23,693 $ 2,811 $ 28,501 $ 28,501 Liabilities Fair value of future policy benefits — — 1,953 1,953 1,953 Derivatives: FIA embedded derivatives, included in contractholder funds — — 3,235 3,235 3,235 Reinsurance related embedded derivative, included in other liabilities — 33 — 33 33 Preferred shares reimbursement feature embedded derivative — — 16 16 16 Total financial liabilities at fair value $ — $ 33 $ 5,204 $ 5,237 $ 5,237 Valuation Methodologies Fixed Maturity Securities & Equity Securities The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met. For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. The Company has an equity investment in a private business development company which is not traded on an exchange or valued by other sources such as analytics or brokers. The Company based the fair value of this investment on an estimated net asset value provided by the investee. Management did not make any adjustments to this valuation. Derivative Financial Instruments The fair value of call option assets represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally, based on industry accepted valuation pricing models which use market-observable inputs, including interest rates, yield curve volatilities, and other factors. The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements) which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the contracts or entered into offsetting positions. These contracts are classified as Level 1. The fair value measurement of the FIA embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs using the option budget method. The market observable inputs are the market value of option and interest swap rates. The significant unobservable inputs are the budgeted option cost (i.e., the expected cost to purchase call options in future periods to fund the equity indexed linked feature), surrender rates, mortality multiplier, and non-performance spread. The mortality multiplier at March 31, 2020 and December 31, 2019 was applied to the Annuity 2000 mortality tables. Increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Increases or decreases in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input. The fair value of the reinsurance-related embedded derivative in the funds withheld reinsurance agreement with Kubera is estimated based upon the fair value of the assets supporting the funds withheld from reinsurance liabilities. The fair value of the assets is based on a quoted market price of similar assets (Level 2), and therefore the fair value of the embedded derivative is based on market-observable inputs and classified as Level 2. The fair value of the Reimbursement Feature is determined using a Black Derman Toy model, incorporating the paid in kind dividend coupon, the Company's redemption option and the preferred shareholder's remarketing feature. The remarketing feature allows the shareholder to put the preferred shares to the Company for a value of par after five years and, if after a successful remarketing event the amount is less than 90% par, up to a maximum of 10% of liquidation price defined. Fair value of this derivative increased $21 during the three months ended March 31, 2020 , due primarily to changes in the credit spread applied in the discount rate. Other Invested Assets Fair value of the AnchorPath embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date. The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date. A Black-Scholes model determines the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model. The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease. FSRC and F&G Re Funds Withheld for Reinsurance Receivables and Future Policy Benefits FSRC and F&G Re elected to apply the Fair Value Option to account for its funds withheld receivables and future policy benefits liability related to its assumed reinsurance. FSRC and F&G Re measures the fair value of the Funds Withheld for Reinsurance Receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the Future Policy Benefits Reserve. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions (plus a risk margin, where applicable) and are consistent with market prices, where available. Risk margins are typically applied to non-observable, non-hedgeable market inputs such as long term volatility, mortality, morbidity, lapse, etc. The significant unobservable inputs used in the fair value measurement of the FSRC and F&G Re future policy benefit liability are undiscounted cash flows, non-performance risk spread and risk margin to reflect uncertainty. Undiscounted cash flows used in our March 31, 2020 discounted cash flow model equaled $(263) . Increases or decreases in non-performance risk spread and risk margin to reflect uncertainty would result in a lower or higher fair value measurement, respectively. Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of March 31, 2020 and December 31, 2019 , are as follows: Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) March 31, 2020 March 31, 2020 Assets Asset-backed securities $ 624 Broker-quoted Offered quotes 91.53% - 112.18% Asset-backed securities 138 Third-Party Valuation Offered quotes 0.00% - 105.02% Commercial mortgage-backed securities 25 Broker-quoted Offered quotes 84.49% - 119.30% Corporates 293 Broker-quoted Offered quotes 82.38% - 102.13% Corporates 906 Third-Party Valuation Offered quotes 59.84% - 116.89% Hybrids 3 Third-Party Valuation Offered quotes 100.80% - 100.80% Municipals 39 Third-Party Valuation Offered quotes 118.01% - 118.01% Residential mortgage-backed securities 500 Broker-quoted Offered quotes 0.00% - 103.20% Residential mortgage-backed securities 7 Third-Party Valuation Offered quotes 95.61% - 95.61% Foreign governments 16 Third-Party Valuation Offered quotes 102.02% - 102.85% Equity securities (Salus preferred equity) 1 Income-Approach Yield 2.33% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 17 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 23 Broker-quoted Offered quotes 100.00% Total financial assets at fair value $ 2,592 Liabilities Future policy benefits 1,904 Discounted cash flow Market value of option 0.00% - 5.37% Mortality multiplier 80.00% - 120.00% Surrender rates 0.50% - 55.00% Partial withdrawals 0.00% - 4.00% Non-performance spread 0.00% - 0.17% Option cost 0.00% - 5.00% Risk margin to reflect uncertainty 0.31% - 0.96% Morbidity risk margin 0.00% - 2.00% Derivatives: FIA embedded derivatives included in contractholder funds 3,303 Discounted cash flow Market value of option 0.00% - 26.37% SWAP rates 0.52% - 0.72% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Partial withdrawals 2.00% - 3.50% Non-performance spread 0.25% - 0.25% Option cost 0.09% - 16.61% Preferred shares reimbursement feature embedded derivative 37 Black Derman Toy model Credit Spread 7.51% Yield Volatility 20% Total financial liabilities at fair value $ 5,244 Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2019 December 31, 2019 Assets Asset-backed securities $ 801 Broker-quoted Offered quotes 98.65% - 119.35% Asset-backed securities 27 Third-Party Valuation Offered quotes 0.00% - 99.43% Commercial mortgage-backed securities 27 Broker-quoted Offered quotes 100.15% - 127.60% Corporates 346 Broker-quoted Offered quotes 83.51% - 106.73% Corporates 946 Third-Party Valuation Offered quotes 98.58% - 119.44% Hybrids 10 Third-Party Valuation Offered quotes 104.72% - 104.72% Municipals 42 Third-Party Valuation Offered quotes 127.68% - 127.68% Residential mortgage-backed securities 546 Broker-quoted Offered quotes 0.00% - 106.50% Foreign governments 18 Third-Party Valuation Offered quotes 110.12% - 118.09% Equity securities (Salus preferred equity) 1 Income-Approach Yield 2.47% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 21 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables at fair value 1 Broker-quoted Offered quotes 100.00% Total financial assets at fair value $ 2,811 Liabilities Future policy benefits 1,953 Discounted cash flow Market value of option 0.00% - 11.20% (2.50%) Mortality multiplier 80.00% - 120.00% (95.46%) Surrender rates 0.00% - 55.00% (21.18%) Partial withdrawals 0.00% - 4.00% (2.28%) Non-performance spread 0.00% - 0.08% (0.03%) Option cost 0.00% - 5.02% (1.28%) Risk margin to reflect uncertainty 0.23% - 0.96% (0.34%) Morbidity risk margin 0.00% - 2.00% (0.07%) Derivatives: FIA embedded derivatives included in contractholder funds 3,235 Discounted cash flow Market value of option 0.00% - 32.54% SWAP rates 1.73% - 1.90% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Partial withdrawals 2.00% - 3.50% Non-performance spread 0.25% - 0.25% Option cost 0.18% - 16.61% Preferred shares reimbursement feature embedded derivative 16 Black Derman Toy model Credit Spread 3.81% Yield Volatility 20% Total financial liabilities at fair value $ 5,204 The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three months ended March 31, 2020 and 2019 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended March 31, 2020 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 828 $ (2 ) $ (34 ) $ 147 $ — $ (158 ) $ (19 ) $ 762 $ (34 ) Commercial mortgage-backed securities 27 — (2 ) — — — — 25 (2 ) Corporates 1,292 — (73 ) 1 — (21 ) — 1,199 (73 ) Hybrids 10 — (1 ) — — (6 ) — 3 (1 ) Municipals 42 — (3 ) — — — — 39 (3 ) Residential mortgage-backed securities 546 — (17 ) 5 — (21 ) (6 ) 507 (17 ) Foreign Governments 18 — (2 ) — — — — 16 (2 ) Equity securities 1 — — — — — — 1 — Other invested assets: Available-for-sale embedded derivative 21 (4 ) — — — — — 17 — Credit linked note 25 — (2 ) — — — — 23 — Funds withheld for reinsurance receivables, at fair value 1 — — — — — (1 ) — — Total assets at Level 3 fair value $ 2,811 $ (6 ) $ (134 ) $ 153 $ — $ (206 ) $ (26 ) $ 2,592 (132 ) Liabilities Future policy benefits $ 1,953 $ (100 ) $ (3 ) $ — $ — $ 54 $ — $ 1,904 $ — FIA embedded derivatives, included in contractholder funds 3,235 279 — 140 (47 ) (304 ) — 3,303 — Preferred shares reimbursement feature embedded derivative 16 21 37 — Total liabilities at Level 3 fair value $ 5,204 $ 200 $ (3 ) $ 140 $ (47 ) $ (250 ) $ — $ 5,244 $ — (a) The net transfers out of Level 3 during the three months ended March 31, 2020 were exclusively to Level 2. Three months ended March 31, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 5 $ 114 $ — $ (31 ) $ (24 ) $ 508 Commercial mortgage-backed securities 67 — 2 — — (1 ) — 68 Corporates 1,231 (1 ) 24 — (21 ) (35 ) 11 1,209 Hybrids 10 — — — — — — 10 Municipals 37 — 1 — — — — 38 Residential mortgage-backed securities 614 — 16 7 — (18 ) — 619 Foreign Governments 16 — — — — — — 16 Equity securities 4 — 1 — — — 15 20 Other invested assets: Available-for-sale embedded derivative 14 2 — — — — — 2 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value 4 — — 5 — — (2 ) 7 Total assets at Level 3 fair value $ 2,466 $ 1 $ 49 $ 126 $ (21 ) $ (85 ) $ — $ 2,536 Liabilities Future policy benefits (FSRC) $ 725 $ 29 $ — $ — $ — $ 43 $ — $ 797 FIA embedded derivatives, included in contractholder funds 2,476 59 — 127 (33 ) 91 — 2,720 Preferred shares reimbursements feature embedded derivative 29 (2 ) — — — — — 27 Total liabilities at Level 3 fair value $ 3,230 $ 86 $ — $ 127 $ (33 ) $ 134 $ — $ 3,544 (a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2. Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments. FHLB Common Stock The fair value of FHLB common stock is based on cost. Mortgage Loans The fair value of mortgage loans is established using a discounted cash flow method based on internal credit rating, maturity and future income. This yield-based approach is sourced from our third-party vendor. The internal ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy. Policy Loans (included within Other Invested Assets) Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk. Loans with similar characteristics are aggregated for purposes of the calculations. Affiliated Other Invested Assets (included within Other Invested Assets) The fair value of the affiliated bank loan is estimated using a discounted cash flow method based on the weighted average cost of capital ("WACC"). This yield-based approach is sourced from a third-party vendor and the WACC establishes a market participant discount rate by determining the hypothetical capital structure for the asset should it be underwritten as of each period end. Investment Contracts Investment contracts include deferred annuities, FIAs, indexed universal life policies ("IULs") and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value. Debt and Revolving Credit Facility The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy. Our revolving credit facility debt is classified as Level 3 within the fair value hierarchy, and the estimated fair value reflects the carrying value as the revolver has no maturity date. The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the unaudited Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described. March 31, 2020 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 65 $ — $ 65 $ 65 Commercial mortgage loans — — 507 507 487 Residential mortgage loans — — 1,297 1,297 1,282 Policy loans, included in other invested assets — — 19 19 29 Affiliated other invested assets — — 26 26 28 Company-owned life insurance 264 264 264 Total $ — $ 65 $ 2,113 $ 2,178 $ 2,155 Liabilities Investment contracts, included in contractholder funds — — 19,915 19,915 22,923 Debt — 537 — 537 543 Total $ — $ 537 $ 19,915 $ 20,452 $ 23,466 December 31, 2019 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 62 $ — $ 62 $ 62 Commercial mortgage loans — — 435 435 422 Residential mortgage loans — — 848 848 845 Policy loans, included in other invested assets — — 14 14 28 Company-owned life insurance — — 129 129 129 Affiliated other invested assets — — 28 28 28 Funds withheld for reinsurance receivables, at fair value — — 1 1 1 Total $ — $ 62 $ 1,455 $ 1,517 $ 1,515 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 19,285 $ 19,285 $ 22,449 Debt — 578 — 578 542 Total $ — $ 578 $ 19,285 $ 19,863 $ 22,991 The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2019 Form 10-K. Carrying Value After Measurement March 31, 2020 December 31, 2019 Equity securities $ — $ 69 Limited partnership investment, included in other invested assets 1,065 1,010 For investments for which NAV is used as a practical expedient for fair value, the Company does not have any significant restrictions in their ability to liquidate their positions in these investments, other than obtaining general partner approval, nor does the Company believe it is probable a price less than NAV would be received in the event of a liquidation. Equity method investments are reported on a lag of up to three months for investee information not received sufficiently timely. For the quarter ended March 31, 2020, the Company received updated NAVs on two investments reported on a lag that showed a decline in valuation of $20 which will be reported in the next quarter period end.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangibles A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows: VOBA DAC DSI Total Balance at December 31, 2019 $ 593 $ 630 $ 232 $ 1,455 Deferrals — 106 27 133 Amortization 19 25 12 56 Interest 4 5 1 10 Unlocking (5 ) (1 ) 1 (5 ) Adjustment for net unrealized investment (gains) losses 262 79 39 380 Balance at March 31, 2020 $ 873 $ 844 $ 312 $ 2,029 VOBA DAC DSI Total Balance at December 31, 2018 $ 866 $ 344 $ 149 $ 1,359 Deferrals — 91 35 126 Amortization (31 ) (3 ) (2 ) (36 ) Interest 4 2 1 7 Unlocking — — — — Adjustment for net unrealized investment (gains) losses (35 ) — — (35 ) Balance at March 31, 2019 $ 804 $ 434 $ 183 $ 1,421 Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01% . The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of March 31, 2020 and 2019 , the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $155 and $40 , respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $9 and $5 , respectively, and the DSI balance included net unrealized investment (gains) losses of $10 and $2 , respectively. Estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year 2020 63 2021 86 2022 83 2023 74 2024 66 Thereafter 347 The Company had an unearned revenue liability balance of $(87) as of March 31, 2020 , including deferrals of $(12) , amortization of $(2) , interest of $(1) , unlocking of $1 and adjustment for net unrealized investment gains (losses) of $(30) . The Company had an unearned revenue liability balance of $(39) as of March 31, 2019 , including deferrals of $(9) , amortization of $2 , unlocking of $0 and adjustment for net unrealized investment gains (losses) of $9 . Definite and Indefinite Lived Intangible Assets Other intangible assets as of March 31, 2020 consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) Trade marks / trade names $ 16 $ 4 $ 12 10 State insurance licenses 6 N/A 6 Indefinite Total $ 18

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt	Debt The carrying amount of the Company's outstanding debt as of March 31, 2020 and December 31, 2019 is as follows: March 31, 2020 December 31, 2019 Debt $ 543 $ 542 As of March 31, 2020 and December 31, 2019 , the Company had not drawn on the revolving credit facility (the "revolver"), which would have carried interest rates equal to 3.74% and 4.55% , respectively, had we drawn on the revolver. As of March 31, 2020 and December 31, 2019 , the amount available to be drawn on the revolver was $250 . The revolver has a maturity date of April 2025. The interest expense for the three months ended March 31, 2020 and 2019 was $8 and $8 , respectively.

Equity

Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Equity	Equity Share Repurchases On December 19, 2018, the Company's Board of Directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020 , and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company. During the three months ended March 31, 2020 , the Company did not repurchase any shares under the repurchase program. As of March 31, 2020 , the Company had repurchased a total of 8,652 thousand shares for a total cost of $69 . Dividends The Company declared the following cash dividend to its common shareholders during the three months ended March 31, 2020 . Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid February 26, 2020 March 30, 2020 March 16, 2020 222,119 $0.01 $2 On May 6, 2020, the Company's Board of Directors will declare a quarterly cash dividend of $0.01 per share. The dividend will be paid on June 8, 2020 to shareholders of record as of May 26, 2020. The Company declared the following cash dividend to its common shareholders during the three months ended March 31, 2019 . Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid February 27, 2019 April 1, 2019 March 18, 2019 221,661 $0.01 $2 The Company declared the following dividends to its preferred shareholders during the three months ended March 31, 2020 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 31, 2020 April 1, 2020 March 15, 2020 321 Paid in kind $— 6 Series B Preferred Shares March 31, 2020 April 1, 2020 March 15, 2020 117 Paid in kind $— 2 The Company declared the following dividends to its preferred shareholders during the three months ended March 31, 2019 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 298 Paid in kind $— 6 Series B Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 108 Paid in kind $— 2

Stock Compensation

Stock Compensation	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Stock Compensation	Stock Compensation On August 8, 2017, the Company adopted a stock-based incentive plan (the “FGL Incentive Plan”) that permits the granting of awards in the form of qualified stock options, non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, unrestricted stock, performance-based awards, dividend equivalents, cash awards and any combination of the foregoing. The Company’s Compensation Committee is authorized to grant up to 15,006 thousand equity awards under the Incentive Plan. At March 31, 2020 , 5,714 thousand equity awards are available for future issuance. FGL Incentive Plan A summary of the Company’s outstanding stock options as of March 31, 2020 , and related activity during the three months ended March 31, 2020 , is as follows (share amount in thousands): Stock Option Awards Options Weighted Average Exercise Price Stock options outstanding at December 31, 2019 15,214 $ 9.30 Granted — — Exercised — — Forfeited or expired (97 ) 10.00 Stock options outstanding at March 31, 2020 15,117 9.30 Exercisable at March 31, 2020 1,467 9.31 Vested or projected to vest at March 31, 2020 15,117 9.30 The Company granted 95 thousand restricted shares to directors in the three months ended March 31, 2020 . These shares will vest on December 31, 2020. The total fair value of the restricted shares granted in the three months ended March 31, 2020 was $1 . A summary of the Company’s nonvested restricted shares outstanding as of March 31, 2020 , and related activity during the three months ended , is as follows (share amount in thousands): Restricted Stock Awards Shares Weighted Average Grant Date Fair Value Restricted shares outstanding at December 31, 2019 — $ — Granted 95 10.48 Vested — — Forfeited or expired — — Vested or expected to vest at March 31, 2020 95 10.48 Management Incentive Plan In the three months ended March 31, 2020 , the Company granted 456 thousand phantom units to members of management under a management incentive plan (the "Management Incentive Plan"). The total fair value of the restricted shares granted in the three months ended March 31, 2020 was $5 . The phantom units granted in 2020 vest in three equal installments on each March 15 th from 2021 to 2023, subject to awardees continued service with the Company. At March 31, 2020 , the liability for phantom units of $2 was based on the number of units granted, the elapsed portion of the service period and the fair value of the Company’s common stock on that date which was $9.80 . A summary of the Management Incentive Plan nonvested phantom units outstanding as of March 31, 2020 , and related activity during the three months ended , is as follows (share amount in thousands): Phantom units Shares Weighted Average Grant Date Fair Value Phantom units outstanding at December 31, 2019 745 $ 9.02 Granted 456 10.87 Vested (123 ) 9.14 Forfeited or expired — — Phantom units outstanding at March 31, 2020 1,078 9.79 The Company recognized total stock compensation expense related to the FGL Incentive Plan and Management Incentive Plan is as follows: Three months ended March 31, 2020 Total stock compensation expense 3 Related tax benefit 1 Net stock compensation expense $ 2 The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the unaudited Condensed Consolidated Statements of Operations. Total compensation expense related to the FGL Incentive Plan and Management Incentive Plan not yet recognized as of March 31, 2020 and the weighted-average period over which this expense will be recognized are as follows: Unrecognized Compensation Weighted Average Recognition FGL Incentive Plan 17 3 Management Incentive Plan 10 2 Total unrecognized stock compensation expense $ 27 3

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company is a Cayman-domiciled corporation that has operations in Bermuda and the U.S. Neither the Cayman Islands nor Bermuda impose a corporate income tax. The Company’s U.S. non-life subsidiaries file a consolidated non-life U.S. Federal income tax return. The Company’s U.S. life insurance subsidiaries file a separate life consolidated U.S. Federal income tax return. The life insurance companies will be eligible to join in a consolidated filing with the U.S. non-life companies in 2022. The provision for income taxes represents federal income taxes. The effective tax rate for the three months ended March 31, 2020 was 0% . The effective tax rate for the three months ended March 31, 2019 was 5% . The effective tax rate on pre-tax income for the three months ended March 31, 2020 differs from the U.S Federal statutory rate for 2020 of 21% primarily due to two factors. First, the Company had substantial losses in jurisdictions that do not impose an income tax. Secondly, a valuation allowance was recorded for FSRC for all of its deferred tax assets. The effective tax rate on pre-tax income for the three months ended March 31, 2019 differed from the U.S. Federal statutory rate for 2019 of 21% primarily due to three factors. First, in 2018, a partial valuation allowance was established against the U.S. Life companies' unrealized loss deferred tax assets because there were not sufficient sources of income to recover those assets. During the first quarter of 2019, the unrealized loss position recovered enough that the valuation allowance was no longer needed and it was released. Secondly, the Company had substantial income in jurisdictions that do not impose an income tax. Thirdly, FSRC had significant income for the period which resulted in a valuation allowance release related to the current period income as FSRC had a full valuation allowance on its deferred tax assets. On March 27, 2020, President Trump signed into law the CARES Act, which, along with earlier issued IRS guidance, amended many provisions of the Internal Revenue Code of 1986. The CARES Act, among other things, contains numerous provisions which may benefit the Company. A $1 benefit has been recorded for the three months ended March 31, 2020. We continue to assess the effect of the CARES Act and ongoing government guidance related to COVID-19 that may be issued. As of March 31, 2020 , the Company had a partial valuation allowance of $297 against its deferred tax assets of $561 . The valuation allowance is an offset to the non-life companies and FSRC deferred tax assets, and a partial valuation allowance on the unrealized capital losses on the U.S. life insurance subsidiaries. The non-life insurance company subsidiaries have a history of losses and insufficient sources of future income that would allow for recognition of any of their deferred tax assets. FSRC incurred a large loss in the current quarter which resulted in a cumulative loss position. The Company does not currently have any tax planning strategies sufficient enough to offset those losses. The Company's U.S. life insurance subsidiaries have sources of capital gain income, but not enough to cover all of its unrealized loss deferred tax assets. The valuation allowance is reviewed quarterly and will be maintained until there is sufficient positive evidence, if any, to support a release. At each reporting date, management considers new evidence, both positive and negative, that could impact the future realization of deferred tax assets. Management will consider a release of the valuation allowance once there is sufficient positive evidence that it is more likely than not that the deferred tax assets will be realized. Any release of the valuation allowance will be recorded as a tax benefit increasing net income or other comprehensive income. All other deferred tax assets are more likely than not to be realized based on expectations as to our future taxable income and considering all other available evidence, both positive and negative.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Commitments The Company has unfunded investment commitments as of March 31, 2020 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below: March 31, 2020 Asset Type Other invested assets $ 1,252 Fixed maturity securities, available-for-sale 111 Other assets $ 71 Residential mortgage loans 18 Total $ 1,452 As of March 31, 2020 , the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information. Lease Commitments The Company leases office space under non-cancelable operating leases that expire in May 2021 and January 2031. Rent expense and minimum rental commitments under non-cancelable leases are immaterial. Contingencies Regulatory and Litigation Matters The Company is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of the Company's management and in light of existing insurance and other potential indemnification, reinsurance and established accruals, such litigation is not expected to have a material adverse effect on the Company's financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period. The Company is assessed amounts by state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At March 31, 2020 , the Company has accrued $ 2 for guaranty fund assessments that is expected to be offset by estimated future premium tax deductions of $ 2 . The Company has received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. We have established procedures to periodically compare our in-force life insurance and annuity policies against the Death Master File or similar databases; investigate any identified potential matches to confirm the death of the insured; and determine whether benefits are due and attempt to locate the beneficiaries of any benefits due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We believe we have established sufficient reserves with respect to these matters; however, it is possible that third parties could dispute these amounts and additional payments or additional unreported claims or liabilities could be identified which could be significant and could have a material adverse effect on our results of operations. On June 30, 2017, a putative class action complaint was filed against FGL Insurance, FGL, and FS Holdco II Ltd in the United States District Court for the District of Maryland, captioned Brokerage Insurance Partners v. Fidelity & Guaranty Life Insurance Company, Fidelity & Guaranty Life, FS Holdco II Ltd, and John Doe, No. 17-cv-1815. The complaint alleges that FGL Insurance breached the terms of its agency agreement with Brokerage Insurance Partners (“BIP”) and other agents by changing certain compensation terms. The complaint asserts, among other causes of action, breach of contract, defamation, tortious interference with contract, negligent misrepresentation, and violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”). The complaint seeks to certify a class composed of all persons who entered into an agreement with FGL Insurance to sell life insurance and who sold at least one life insurance policy between January 1, 2015 and January 1, 2017. The complaint seeks unspecified compensatory, consequential, and punitive damages in an amount not presently determinable, among other forms of relief. On September 1, 2017, FGL Insurance filed a counterclaim against BIP and John and Jane Does 1-10, asserting, among other causes of action, breach of contract, fraud, civil conspiracy and violations of RICO. On September 22, 2017, Plaintiff filed an Amended Complaint, and on October 16, 2017, FGL Insurance filed an Amended Counterclaim against BIP, Agent Does 1-10, and Other Person Does 1-10. The parties also filed cross-Motions to Dismiss in Part. On August 17, 2018, the Court in the BIP Litigation denied all pending Motions to Dismiss filed by all parties without prejudice, pending a decision as to whether the BIP Litigation will be consolidated into related litigation, captioned Fidelity & Guaranty Life Insurance Company v. Network Partners, et al., Case No. 17-cv-1508. On August 31, 2018, FGL Insurance filed its Answer to BIP’s Amended Complaint. Also on that date, FGL Insurance filed its Answer to Amended Complaint, Affirmative Defenses, and Counterclaim, Filed Pursuant to Fed. R. Civ. P. 12(a)(4)(A). On October 15, 2019, BIP filed with the Court an Unopposed Motion for Preliminary Approval of Settlement and Class Certification, along with a copy of the Class Action Settlement Agreement signed by all parties. A Fairness Hearing on Plaintiff’s Motion for Preliminary Approval of Class Settlement was held on Monday, January 13, 2020. On January 15, 2020, the Court issued the Modified Findings and Order Preliminarily Approving Class Settlement Between Plaintiff and Defendants, Granting Conditional Certification of Settlement Class, Directing Issuance of Notice to the Class, and Setting of Final Approval Hearing ("Preliminary Approval Order"). In preliminarily approving the Class Settlement, the Court also approved the Settlement Schedule that had been filed by Class Counsel on January 10, 2020. After confirmatory discovery, the Court, on April 22, 2020, amended its Preliminary Approval Order and the Settlement Schedule. Final settlement is subject to, among other requirements, final approval by the Court after Court-approved Notice has been provided to the absent members of the putative class. On September 1, 2020, the Court will hold a hearing to determine whether to grant final approval to the settlement. On April 9, 2020, a complaint was filed in the United States District Court for the District of Delaware against FGL, the members of its board of directors, Fidelity F I Corp. and F II Corp., captioned Sabatini v. FGL Holdings, et al. , Case No. 1:20-cv-00495 (D. Del.). The complaint alleges that the registration statement issued in connection with the proposed merger between FGL and Fidelity omitted material information in violation of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934, rendering the registration statement false and misleading. Specifically, the complaint alleges that the registration statement failed to disclose material information regarding (i) FGL's financial projections, (ii) Houlihan's fairness opinion analyses (including the selected companies, selected transactions, and discounted cash flow analyses); (iii) purported "conflicts" relating to Houlihan, Credit Suisse and CC Capital Partners; and (iv) whether the confidentiality agreement used during the go-shop period contained a standstill or "don't ask, don't waive" provision. The complaint seeks an order enjoining the proposed merger unless and until additional disclosures are issued; rescinding the proposed merger, to the extent it closes; awarding damages; awarding costs, including attorneys’ fees, expert fees and expenses; and awarding such other relief as the court deems proper.

Reinsurance

Reinsurance	3 Months Ended
	Mar. 31, 2020
Reinsurance Disclosures [Abstract]
Reinsurance	Reinsurance The Company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured. The Company primarily seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies. The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the three months ended March 31, 2020 and 2019 were as follows: Three months ended March 31, 2020 March 31, 2019 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct 50 130 57 372 Assumed — (115 ) — 20 Ceded (40 ) (56 ) (41 ) (53 ) Net 10 (41 ) 16 339 Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. The Company did not write off any significant reinsurance balances during the three months ended March 31, 2020 and 2019 . The Company did not commute any ceded reinsurance treaties during the three months ended March 31, 2020 or 2019 . The Company estimated $22 of expected credit losses on reinsurance recoverable balances as of January 1, 2020 and recorded that estimate as a reduction to retained earnings as part of the adoption of ASC 326. The Company estimates expected credit losses on reinsurance recoverables using a probability of default/loss given default model. Significant inputs to the model include the reinsurers credit risk, expected timing of recovery, industry-wide historical default experience, senior unsecured bond recovery rates, and credit enhancement features. During the quarter ended March 31, 2020 , the expected credit loss reserve was not adjusted. No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues. Effective January 1, 2017, FGL Insurance entered into an indemnity reinsurance agreement with Hannover Re, a third party reinsurer, to reinsure an inforce block of its FIA and fixed deferred annuity contracts with guaranteed minimum withdrawal benefits "(GMWB)" and Guaranteed Minimum Death Benefit (“GMDB”) guarantees. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of the net retention of guarantee payments in excess of account value for GMWB and GMDB guarantees. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective July 1, 2017, FGL Insurance extended this agreement to include new business issued during 2017. Effective January 1, 2018 FGL Insurance extended this agreement to include new business issued during 2018, and extended the recapture period from 8 to 12 years. Effective January 1, 2019, FGL Insurance extended this agreement to include new business issued during 2019. FGL Insurance incurred risk charge fees of $5 during the three months ended March 31, 2020 , in relation to this reinsurance agreement. Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $758 of certain MYGA and deferred annuity GAAP reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of MYGA and deferred annuity policies for certain issue years to Kubera. Effective June 30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $185 of MYGA GAAP reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019. Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $4 billion of certain FIA statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of FIA policies for certain issue years to Kubera. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective June 30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $1 billion of FIA statutory reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019. The effects of the amendment are also not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP. F&G Reinsurance Companies FSRC has entered into various reinsurance agreements on a funds withheld basis, meaning that funds are withheld by the ceding company from the coinsurance premium owed to FSRC as collateral for FSRC's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC manages the assets supporting the reserves assumed in accordance with the internal investment policy of the ceding companies and applicable law. At March 31, 2020 , FSRC had $266 of funds withheld receivables and $263 of insurance reserves related to these reinsurance treaties. F&G Re has entered into multiple reinsurance agreements on a funds withheld basis with unaffiliated parties. At March 31, 2020 , F&G Re had $1,784 of funds withheld receivables and $1,641 of insurance reserves related to these reinsurance treaties. See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts in "Note 2. Significant Accounting Policies and Practices" within the Company's 2019 Form 10-K.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions The Company, and certain subsidiaries of the Company, entered into investment management agreements ("IMAs") with Blackstone ISG-I Advisors LLC ("BISGA"), a wholly-owned subsidiary of The Blackstone Group LP ("Blackstone") on December 1, 2017. On December 31, 2019, to be effective as of October 31, 2019, FGL Insurance and certain subsidiaries of the Company entered into amended and restated IMAs (the “Restated IMAs”) with BISGA, pursuant to which BISGA was appointed as investment manager of the Company’s general accounts (the “F&G Accounts”). Pursuant to the terms of the Restated IMAs, BISGA may delegate any or all of its discretionary investment, advisory and other rights, powers, functions and obligations under the Restated IMAs to one or more sub-managers, including its affiliates. BISGA delegated certain investment services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. During the three months ended March 31, 2020 , the fees paid to BISGA under the Restated IMAs and the IMAs were approximately $26 . As of March 31, 2020 and December 31, 2019 , the Company has a net liability of $33 and $47 , respectively, for the services consumed under the Restated IMAs, the IMAs and related sub-management agreements, partially offset by fees received and expense reimbursements from BISGA. During the three months ended March 31, 2020 and 2019 , the Company received expense reimbursements from BISGA for the services consumed under these agreements. Fees received for these types of services are $3 and $2 for the three months ended March 31, 2020 and 2019 , respectively. The Company holds certain fixed income security interests, limited partnerships and bank loans issued by portfolio companies that are affiliates of Blackstone Tactical Opportunities, an affiliate of Blackstone Tactical Opportunities LR Associates-B (Cayman) Ltd (the “Blackstone Fixed Income Securities”) both on a direct and indirect basis. Indirect investments include an investment made in an affiliates’ asset backed fund while direct investments are an investment in affiliates' equity or debt securities. As of March 31, 2020 and December 31, 2019 , the Company held $1,978 and $2,001 in affiliated investments, respectively, which includes foreign exchange unrealized loss of $ (5) and $ (3) , respectively. As of March 31, 2020 and December 31, 2019 , the Company had unfunded commitments relating to affiliated investments of $1,042 and $993 , respectively. The Company purchased $103 of residential loans from Finance of America Holdings LLC, a Blackstone affiliate, and $67 of commercial mortgage loans from Blackstone Real Estate Debt Strategies, a Blackstone affiliate, during the three months ended March 31, 2020 . The Company paid-in-kind dividends on preferred shares held by GSO Capital Partners, an indirect wholly owned subsidiary of The Blackstone Group LP, of 6 thousand shares for the three months ended March 31, 2020 and 2019 . The Company had $(3) and no gross realized gains or realized impairment losses on related party investments during the three months ended March 31, 2020 and 2019

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands): Three months ended March 31, 2020 March 31, 2019 Net income (loss) $ (338 ) $ 171 Less Preferred stock dividend 8 8 Net income (loss) available to common shares (346 ) 163 Weighted-average common shares outstanding - basic 213,155 219,646 Dilutive effect of unvested restricted stock — 36 Weighted-average shares outstanding - diluted 213,155 219,682 Net income (loss) per common share: Basic $ (1.62 ) $ 0.74 Diluted $ (1.62 ) $ 0.74 The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL Holdings shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury. Under applicable accounting guidance, companies in a loss position are required to use basic weighted average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our net loss for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share, as the inclusion of 12 thousand restricted shares and 604 thousand stock options would have been antidilutive to the calculation. If we had not incurred a net loss in the three months ended March 31, 2020, dilutive potential common shares would have been 213,771 thousand . The calculation of diluted earnings per share for the three months ended March 31, 2020 excludes the incremental effect of 6 million weighted average common stock warrants outstanding due to their anti-dilutive effect. This calculation also excludes the potential dilutive effect of the 438 thousand preferred stock shares outstanding as of March 31, 2020 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met. The number of weighted average equivalent shares excluded is 276 thousand shares for the three months ended March 31, 2020 . The calculation of diluted earnings per share for the three months ended March 31, 2019 excludes the incremental effect of 6 million weighted average common stock warrants outstanding due to their anti-dilutive effect. This calculation also excludes the potential dilutive effect of the 406 thousand preferred stock shares outstanding as of March 31, 2019 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met. The calculation of diluted earnings per share for the three months ended March 31, 2019 excludes the incremental effect related to certain outstanding stock options due to their anti-dilutive effect. The number of weighted average equivalent shares excluded is 1,737 shares for the three months ended March 31, 2019

Insurance Subsidiary Financial

Insurance Subsidiary Financial Information and Regulatory Matters	3 Months Ended
	Mar. 31, 2020
Insurance [Abstract]
Insurance Subsidiary Financial Information and Regulatory Matters	Insurance Subsidiary Financial Information and Regulatory Matters The Company’s U.S. insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect DAC, DSI and VOBA, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. FSRC (Cayman), F&G Re (Bermuda), and F&G Life Re (Bermuda) file financial statements with their respective regulators that are based on U.S. GAAP. FGL Insurance applies Iowa-prescribed accounting practices that permit Iowa-domiciled insurers to report equity call options used to economically hedge FIA index credits at amortized cost for statutory accounting purposes and to calculate FIA statutory reserves such that index credit returns will be included in the reserve only after crediting to the annuity contract. This resulted in a $ 13 increase and $110 decrease to statutory capital and surplus at March 31, 2020 and December 31, 2019 , respectively. FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $ 100 at March 31, 2020 and December 31, 2019 . Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $ 1 and $6 at March 31, 2020 and December 31, 2019 , respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and surplus (deficit) would be $ (10) and $(19) as of March 31, 2020 and December 31, 2019 , respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent. FGL Insurance’s statutory carrying value of Raven Re at March 31, 2020 and December 31, 2019 was $ 92 and $87 , respectively. As of March 31, 2020 , FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices.

Significant Accounting Polici_2

Significant Accounting Policies and Practices (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all other entities in which the Company has a controlling financial interest and any variable interest entities ("VIEs") in which we are the primary beneficiary. All intercompany accounts and transactions have been eliminated in consolidation.
VIE	We are involved in certain entities that are considered VIEs as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control, to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our unaudited condensed consolidated financial statements . See "Note 4. Investments" to the Company’s unaudited condensed consolidated financial statements for additional information on VIEs.
Significant Accounting Policies and Practices	Adoption of New Accounting Pronouncements Test for Goodwill Impairment In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment , effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update: • the subsequent measurement of goodwill is simplified by the elimination of step 2 from the goodwill impairment test, which required an entity to determine the implied fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination • the entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, not to exceed the total amount of goodwill allocated to that reporting unit • the entity is no longer required to perform a qualitative assessment for any reporting unit with a zero or negative carrying amount The Company adopted this standard on January 1, 2020, and it did not impact its unaudited condensed consolidated financial statements. Fair Value Measurement In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update: • for investments in certain entities that calculate net asset value, investors are required to disclose the timing of liquidation of an investee's assets and the date when restrictions from redemption might lapse if the investee has communicated timing to the entity or announced timing publicly • entities should use the measurement uncertainty disclosure to communicate information about the uncertainty in measurement as of the reporting date • entities must disclose changes in unrealized gains and losses included in other comprehensive income for recurring Level 3 fair value measurements, as well as the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, or other quantitative information in lieu of weighted average if the entity determines such information would be more reasonable and rational • entities are no longer required to disclose the amounts and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements The Company adopted this standard on January 1, 2020, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Consolidation In October 2018, the FASB issued ASU 2018-17, Consolidation (Topic 810), Targeted Improvements to Related Party Guidance for Variable Interest Entities, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update, entities must consider indirect interests held through related parties under common control on a proportional basis to determine whether a decision-making fee is a variable interest. The Company adopted this standard on January 1, 2020, and it did not impact its unaudited condensed consolidated financial statements. New Credit Loss Standard In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (ASC 326), Measurement of Credit Losses on Financial Instruments , effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Since its release, certain targeted improvements and transition relief amendments have been made to ASU 2016-13 and have been published in ASU 2018-19, ASU 2019-04, ASU 2019-05 and ASU 2019-11. Collectively, these ASUs changed the accounting for impairment of most financial assets and certain other instruments in the following ways: • financial assets (or a group of financial assets) measured at amortized cost are required to be presented at the net amount expected to be collected, with an allowance for expected credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount • credit losses relating to available-for-sale ("AFS") fixed maturity securities generally are recorded through an allowance for expected credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for expected credit losses for AFS fixed maturity securities is limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value • the income statement reflects the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount The Company adopted this standard effective January 1, 2020 using a modified-retrospective approach, as required. As a result of adoption, the Company recorded a cumulative-effect adjustment, which decreased retained earnings by $24 , net of tax. We recorded offsetting increases to the allowance for expected credit losses for mortgage loans and reinsurance recoverables and a decrease for deferred tax impacts. Refer to Note 4. "Investments" and Note 13. "Reinsurance" for additional information. Future Accounting Pronouncements Long-Duration Insurance Contracts In August 2018, the FASB issued ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts , effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Under this update: • assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations • the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income • market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income • deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts • deferred acquisition costs must be written off for unexpected contract terminations • disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements. Simplifying the Accounting for Income Taxes In December 2019, the FASB issued ASU 2019-12 Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes , effective for the fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update: • accounting for income taxes is simplified by removing certain exceptions, including exceptions related to the incremental approach for intraperiod tax allocation, calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences • the accounting for franchise taxes, transactions that result in a step-up in the tax basis of goodwill and enacted changes in tax laws or rates has been clarified • the consolidated amount of current and deferred tax expense to a legal entity that is not subject to tax in its separate financial statements is not required to be allocated, although the entity may elect to do so

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]
Financing Receivable Credit Quality Indicators [Table Text Block]		Loans segregated by risk rating exposure as at March 31, 2020 , was as follows: March 31, 2020 Term Loans Amortized Cost by Origination Year 2020 2019 2018 2017 2016 Prior Total Residential mortgages Current (less than 30 days past due) 304 671 73 48 63 3 1,162 30-89 days past due 12 100 6 — 2 — 120 Over 90 days past due — 9 2 — — — 11 Total residential mortgages 316 780 81 48 65 3 1,293 Commercial mortgages Current (less than 30 days past due) 68 — 6 — 11 403 488 30-89 days past due — — — — — — — Over 90 days past due — — — — — — — Total commercial mortgage 68 — 6 — 11 403 488 March 31, 2020 Term Loans Amortized Cost by Origination Year 2020 2019 2018 2017 2016 Prior Total Commercial mortgages LTV Less than 50% — — 6 — — 278 284 50% to 60% 34 — — — — 125 159 60% to 75% 34 — — — 11 — 45 Total commercial mortgages 68 — 6 — 11 403 488 Commercial mortgages DSCR Greater than 1.25x 68 — 6 — 11 397 482 1.00x - 1.25x — — — — — 6 6 Less than 1.00x — — — — — — — Total commercial mortgages 68 — 6 — 11 403 488
Consolidated Investments	The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income (loss). The Company’s consolidated investments at March 31, 2020 and December 31, 2019 are summarized as follows: March 31, 2020 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 5,785 $ (17 ) $ 26 $ (849 ) $ 4,945 $ 4,945 Commercial mortgage-backed securities 2,848 — 16 (383 ) 2,481 2,481 Corporates 10,898 (21 ) 366 (792 ) 10,451 10,451 Hybrids 976 — 5 (90 ) 891 891 Municipals 1,270 — 63 (15 ) 1,318 1,318 Residential mortgage-backed securities 884 (6 ) 17 (25 ) 870 870 U.S. Government 40 — 3 — 43 43 Foreign Governments 135 — 7 (1 ) 141 141 Total available-for-sale securities 22,836 (44 ) 503 (2,155 ) 21,140 21,140 Equity securities 1,052 1 (138 ) 915 915 Derivative investments 380 13 (205 ) 188 188 Commercial mortgage loans 488 (1 ) — — 507 487 Residential mortgage loans 1,293 (11 ) — — 1,297 1,282 Other invested assets 1,497 — (6 ) 1,479 1,491 Total investments $ 27,546 $ (56 ) $ 517 $ (2,504 ) $ 25,526 $ 25,503 December 31, 2019 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 5,720 $ 51 $ (77 ) $ 5,694 $ 5,694 Commercial mortgage-backed securities 2,788 140 (6 ) 2,922 2,922 Corporates 11,051 618 (72 ) 11,597 11,597 Hybrids 983 48 (4 ) 1,027 1,027 Municipals 1,284 64 (5 ) 1,343 1,343 Residential mortgage-backed securities 917 40 (3 ) 954 954 U.S. Government 33 1 — 34 34 Foreign Governments 138 17 — 155 155 Total available-for-sale securities 22,914 979 (167 ) 23,726 23,726 Equity securities 1,069 19 (17 ) 1,071 1,071 Derivative investments 336 261 (10 ) 587 587 Commercial mortgage loans 422 — — 435 422 Residential mortgage loans 845 — — 848 845 Other invested assets 1,306 — (3 ) 1,288 1,303 Total investments $ 26,892 $ 1,259 $ (197 ) $ 27,955 $ 27,954
Investments Classified by Contractual Maturity Date [Table Text Block]	The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations. March 31, 2020 Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 84 $ 80 Due after one year through five years 915 870 Due after five years through ten years 1,942 1,872 Due after ten years 10,378 10,022 Subtotal 13,319 12,844 Other securities which provide for periodic payments: Asset-backed securities 5,785 4,945 Commercial mortgage-backed securities 2,848 2,481 Residential mortgage-backed securities 884 870 Subtotal 9,517 8,296 Total fixed maturity available-for-sale securities $ 22,836 $ 21,140
Debt Securities, Available-for-sale, Allowance for Credit Loss [Table Text Block]		The activity in the allowance for expected credit losses of available-for-sale securities aggregated by investment category were as follows: For the quarter ended March 31, 2020 Additions Reductions Balance at Beginning of Period For credit losses on securities for which losses were not previously recorded For initial credit losses on purchased securities accounted for as PCD financial assets (a) Additions (reductions) in allowance recorded on previously impaired securities For securities sold during the period For securities intended/required to be sold prior to recovery of amortized cost basis Writeoffs charged against the allowance Balance at End of Period Available-for-sale securities Asset-backed securities — (17 ) — — — — — (17 ) Commercial mortgage-backed securities — — — — — — — — Corporates — (22 ) — — — — 1 (21 ) Hybrids — — — — — — — — Municipals — — — — — — — — Residential mortgage-backed securities — (6 ) — — — — — (6 ) US Government — — — — — — — — Foreign Government — — — — — — — — Total available-for-sale securities $ — $ (45 ) $ — $ — $ — $ — $ 1 $ (44 ) (a) Purchased credit deteriorated financial assets ("PCD")
Fair Value and Gross Unrealized Losses of Available-for-Sale-Securities	The fair value and gross unrealized losses of available-for-sale securities, excluding securities in an unrealized losses position with an allowance for expected credit loss, aggregated by investment category and duration of fair value below amortized cost as of March 31, 2020, were as follows: March 31, 2020 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 2,872 $ (518 ) $ 1,322 $ (325 ) $ 4,194 $ (843 ) Commercial mortgage-backed securities 2,073 (378 ) 13 (5 ) 2,086 (383 ) Corporates 4,691 (644 ) 239 (144 ) 4,930 (788 ) Hybrids 669 (79 ) 31 (11 ) 700 (90 ) Municipals 323 (12 ) 51 (3 ) 374 (15 ) Residential mortgage-backed securities 146 (13 ) 65 (6 ) 211 (19 ) Foreign Government 33 (1 ) — — 33 (1 ) Total available-for-sale securities $ 10,807 $ (1,645 ) $ 1,721 $ (494 ) $ 12,528 $ (2,139 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,365 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 294 Total number of available-for-sale securities in an unrealized loss position 1,659 The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost as of December 31, 2019, were as follows: December 31, 2019 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 719 $ (12 ) $ 2,453 $ (65 ) $ 3,172 $ (77 ) Commercial mortgage-backed securities 232 (4 ) 16 (2 ) 248 (6 ) Corporates 1,030 (25 ) 804 (47 ) 1,834 (72 ) Hybrids 23 (1 ) 60 (3 ) 83 (4 ) Municipals 123 (2 ) 60 (3 ) 183 (5 ) Residential mortgage-backed securities 41 — 107 (3 ) 148 (3 ) U.S. Government 6 — — — 6 — Total available-for-sale securities $ 2,174 $ (44 ) $ 3,500 $ (123 ) $ 5,674 $ (167 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 290 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 446 Total number of available-for-sale securities in an unrealized loss position 736
Reconciliation of Other-than-Temporary Impairment on Fixed Maturity	Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows: Three months ended March 31, 2019 Corporates $ (2 ) Total $ (2 ) The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the three months ended March 31, 2019 : Three months ended March 31, 2019 Credit impairment losses in operations $ (2 ) Change-of-intent losses in operations — Amortized cost 1 Fair value 1 Non-credit losses in other comprehensive income for investments which experienced OTTI — The following table provides a reconciliation of the beginning and ending balances within AOCI of the non-credit loss portion of impairment on fixed maturity available-for-sale securities held by the Company for the three months ended March 31, 2019 : Three months ended March 31, 2019 Beginning balance $ — Increases attributable to credit losses on securities: OTTI was previously recognized — OTTI was not previously recognized — Ending balance $ —
Schedule of Accounts, Notes, Loans and Financing Receivable	The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: March 31, 2020 December 31, 2019 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: Hotel $ 21 4 % $ 21 5 % Industrial - General 37 8 % 37 9 % Industrial - Warehouse 20 4 % 20 4 % Multifamily 121 25 % 54 13 % Office 142 29 % 143 34 % Retail 147 30 % 147 35 % Total commercial mortgage loans, gross of valuation allowance $ 488 100 % $ 422 100 % Allowance for expected credit loss (1 ) — Total commercial mortgage loans $ 487 $ 422 U.S. Region: East North Central $ 64 13 % $ 64 15 % East South Central 53 11 % 19 5 % Middle Atlantic 77 16 % 77 18 % Mountain 51 10 % 51 12 % New England 4 1 % 4 1 % Pacific 112 23 % 113 27 % South Atlantic 55 11 % 56 13 % West North Central 13 3 % 13 3 % West South Central 59 12 % 25 6 % Total commercial mortgage loans, gross of valuation allowance $ 488 100 % $ 422 100 % Allowance for expected credit loss (1 ) — Total commercial mortgage loans $ 487 $ 422
Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios	The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at March 31, 2020 and December 31, 2019 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 March 31, 2020 LTV Ratios: Less than 50% $ 278 $ 6 $ 284 58 % $ 295 58 % 50% to 60% 159 — 159 33 % 166 33 % 60% to 75% 44 — 44 9 % 46 9 % Commercial mortgage loans $ 481 $ 6 $ 487 100 % $ 507 100 % December 31, 2019 LTV Ratios: Less than 50% $ 346 $ 6 $ 352 83 % $ 363 83 % 50% to 60% 70 — 70 17 % 72 17 % Commercial mortgage loans $ 416 $ 6 $ 422 100 % $ 435 100 %
Financing Receivable, Allowance for Credit Loss [Table Text Block]	Changes in the Company’s allowance for expected credit losses on commercial mortgage loans are recognized in “Net investment gains (losses)” in the accompanying unaudited Condensed Consolidated Statements of Operations. Residential Mortgage Loans Commercial Mortgage Loans Total Balance as at January 1, 2020 7 1 8 (Reversal of) provision for loan losses 4 — 4 Balance as at March 31, 2020 11 1 12
Financing Receivable, Nonaccrual [Table Text Block]	An allowance for expected credit loss is not measured on accrued interest income for commercial mortgage loans as the Company has a process to write-off interest on loans that enter in to non-accrual status (over 90 days past due). March 31, 2020 Residential Mortgage Loans 11 Commercial Mortgage Loans — Total loans that are 90 days or more past due and still accruing 11

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows: March 31, 2020 December 31, 2019 Assets: Derivative investments: Call options $ 188 $ 587 Other Invested Assets: Other embedded derivatives 17 21 Funds withheld: Call options 1 3 $ 206 $ 611 Liabilities: Contractholder funds: FIA embedded derivative $ 3,303 $ 3,235 Other liabilities: Futures contracts 2 — Reinsurance related embedded derivative (18 ) 33 Preferred shares reimbursement feature embedded derivative 37 16 $ 3,324 $ 3,284
FGL's Exposure to Credit Loss on Call Options Held	Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table: March 31, 2020 Counterparty Credit Rating (Fitch/Moody's/S&P) (a) Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 2,583 $ 7 $ — $ 7 Deutsche Bank BBB/A3/BBB+ 35 2 1 1 Morgan Stanley */A1/A+ 2,162 8 9 — Barclay's Bank A+/A1/A 4,521 115 110 5 Canadian Imperial Bank of Commerce AA/Aa2/A+ 2,727 31 25 6 Wells Fargo A+/A2/A- 2,558 21 26 — Goldman Sachs A/A3/BBB+ 1,112 5 3 2 Total $ 15,698 $ 189 $ 174 $ 21 December 31, 2019 Counterparty Credit Rating Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 2,718 $ 88 $ 43 $ 45 Deutsche Bank BBB/A3/BBB+ 157 7 7 — Morgan Stanley */A1/A+ 2,053 66 65 1 Barclay's Bank A+/A2/A 4,290 211 193 18 Canadian Imperial Bank of Commerce */Aa2/A+ 2,691 106 74 32 Wells Fargo A+/A2/A- 2,165 81 80 1 Goldman Sachs A/A3/BBB+ 1,065 31 27 4 Total $ 15,139 $ 590 $ 489 $ 101 (a) An * represents credit ratings that were not available.
Derivative Instruments, Gain (Loss) [Table Text Block]	The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows: Three months ended March 31, 2020 March 31, 2019 Net investment gains (losses): Call options $ (360 ) $ 154 Futures contracts — 8 Foreign currency forward 2 2 Other derivatives and embedded derivatives (4 ) 3 Reinsurance related embedded derivatives (161 ) (3 ) Total net investment gains (losses) $ (523 ) $ 164 Benefits and other changes in policy reserves: FIA embedded derivatives $ 68 $ 244 Acquisition and operating expenses, net of deferrals: Preferred shares reimbursement feature embedded derivative $ 21 $ (2 )

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Assets and Liabilities Carrying at Fair Value on Recurring Basis	The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows: March 31, 2020 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 776 $ — $ — $ 776 $ 776 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,183 762 4,945 4,945 Commercial mortgage-backed securities — 2,456 25 2,481 2,481 Corporates — 9,252 1,199 10,451 10,451 Hybrids 267 621 3 891 891 Municipals — 1,279 39 1,318 1,318 Residential mortgage-backed securities — 363 507 870 870 U.S. Government 37 6 — 43 43 Foreign Governments — 125 16 141 141 Equity securities 365 549 1 915 915 Derivative investments — 188 — 188 188 Other invested assets — — 40 40 40 Funds withheld for reinsurance receivables, at fair value 289 1,761 — 2,050 2,050 Total financial assets at fair value $ 1,734 $ 20,783 $ 2,592 $ 25,109 $ 25,109 Liabilities Fair value of future policy benefits — — 1,904 1,904 1,904 Derivatives: FIA embedded derivatives, included in contractholder funds — — 3,303 3,303 3,303 Reinsurance related embedded derivative, included in other liabilities — (18 ) — (18 ) (18 ) Derivative instruments - futures contracts 2 — — 2 2 Preferred shares reimbursement feature embedded derivative — — 37 37 37 Total financial liabilities at fair value $ 2 $ (18 ) $ 5,244 $ 5,228 $ 5,228 December 31, 2019 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 969 $ — $ — $ 969 $ 969 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,866 828 5,694 5,694 Commercial mortgage-backed securities — 2,895 27 2,922 2,922 Corporates — 10,305 1,292 11,597 11,597 Hybrids 299 718 10 1,027 1,027 Municipals — 1,301 42 1,343 1,343 Residential mortgage-backed securities — 408 546 954 954 U.S. Government 28 6 — 34 34 Foreign Governments — 137 18 155 155 Equity securities 387 614 1 1,002 1,002 Derivative investments — 587 — 587 587 Other invested assets — — 46 46 46 Funds withheld for reinsurance receivables, at fair value 314 1,856 1 2,171 2,171 Total financial assets at fair value $ 1,997 $ 23,693 $ 2,811 $ 28,501 $ 28,501 Liabilities Fair value of future policy benefits — — 1,953 1,953 1,953 Derivatives: FIA embedded derivatives, included in contractholder funds — — 3,235 3,235 3,235 Reinsurance related embedded derivative, included in other liabilities — 33 — 33 33 Preferred shares reimbursement feature embedded derivative — — 16 16 16 Total financial liabilities at fair value $ — $ 33 $ 5,204 $ 5,237 $ 5,237 The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the unaudited Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described. March 31, 2020 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 65 $ — $ 65 $ 65 Commercial mortgage loans — — 507 507 487 Residential mortgage loans — — 1,297 1,297 1,282 Policy loans, included in other invested assets — — 19 19 29 Affiliated other invested assets — — 26 26 28 Company-owned life insurance 264 264 264 Total $ — $ 65 $ 2,113 $ 2,178 $ 2,155 Liabilities Investment contracts, included in contractholder funds — — 19,915 19,915 22,923 Debt — 537 — 537 543 Total $ — $ 537 $ 19,915 $ 20,452 $ 23,466 December 31, 2019 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 62 $ — $ 62 $ 62 Commercial mortgage loans — — 435 435 422 Residential mortgage loans — — 848 848 845 Policy loans, included in other invested assets — — 14 14 28 Company-owned life insurance — — 129 129 129 Affiliated other invested assets — — 28 28 28 Funds withheld for reinsurance receivables, at fair value — — 1 1 1 Total $ — $ 62 $ 1,455 $ 1,517 $ 1,515 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 19,285 $ 19,285 $ 22,449 Debt — 578 — 578 542 Total $ — $ 578 $ 19,285 $ 19,863 $ 22,991
Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis	Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of March 31, 2020 and December 31, 2019 , are as follows: Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) March 31, 2020 March 31, 2020 Assets Asset-backed securities $ 624 Broker-quoted Offered quotes 91.53% - 112.18% Asset-backed securities 138 Third-Party Valuation Offered quotes 0.00% - 105.02% Commercial mortgage-backed securities 25 Broker-quoted Offered quotes 84.49% - 119.30% Corporates 293 Broker-quoted Offered quotes 82.38% - 102.13% Corporates 906 Third-Party Valuation Offered quotes 59.84% - 116.89% Hybrids 3 Third-Party Valuation Offered quotes 100.80% - 100.80% Municipals 39 Third-Party Valuation Offered quotes 118.01% - 118.01% Residential mortgage-backed securities 500 Broker-quoted Offered quotes 0.00% - 103.20% Residential mortgage-backed securities 7 Third-Party Valuation Offered quotes 95.61% - 95.61% Foreign governments 16 Third-Party Valuation Offered quotes 102.02% - 102.85% Equity securities (Salus preferred equity) 1 Income-Approach Yield 2.33% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 17 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 23 Broker-quoted Offered quotes 100.00% Total financial assets at fair value $ 2,592 Liabilities Future policy benefits 1,904 Discounted cash flow Market value of option 0.00% - 5.37% Mortality multiplier 80.00% - 120.00% Surrender rates 0.50% - 55.00% Partial withdrawals 0.00% - 4.00% Non-performance spread 0.00% - 0.17% Option cost 0.00% - 5.00% Risk margin to reflect uncertainty 0.31% - 0.96% Morbidity risk margin 0.00% - 2.00% Derivatives: FIA embedded derivatives included in contractholder funds 3,303 Discounted cash flow Market value of option 0.00% - 26.37% SWAP rates 0.52% - 0.72% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Partial withdrawals 2.00% - 3.50% Non-performance spread 0.25% - 0.25% Option cost 0.09% - 16.61% Preferred shares reimbursement feature embedded derivative 37 Black Derman Toy model Credit Spread 7.51% Yield Volatility 20% Total financial liabilities at fair value $ 5,244 Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2019 December 31, 2019 Assets Asset-backed securities $ 801 Broker-quoted Offered quotes 98.65% - 119.35% Asset-backed securities 27 Third-Party Valuation Offered quotes 0.00% - 99.43% Commercial mortgage-backed securities 27 Broker-quoted Offered quotes 100.15% - 127.60% Corporates 346 Broker-quoted Offered quotes 83.51% - 106.73% Corporates 946 Third-Party Valuation Offered quotes 98.58% - 119.44% Hybrids 10 Third-Party Valuation Offered quotes 104.72% - 104.72% Municipals 42 Third-Party Valuation Offered quotes 127.68% - 127.68% Residential mortgage-backed securities 546 Broker-quoted Offered quotes 0.00% - 106.50% Foreign governments 18 Third-Party Valuation Offered quotes 110.12% - 118.09% Equity securities (Salus preferred equity) 1 Income-Approach Yield 2.47% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 21 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables at fair value 1 Broker-quoted Offered quotes 100.00% Total financial assets at fair value $ 2,811 Liabilities Future policy benefits 1,953 Discounted cash flow Market value of option 0.00% - 11.20% (2.50%) Mortality multiplier 80.00% - 120.00% (95.46%) Surrender rates 0.00% - 55.00% (21.18%) Partial withdrawals 0.00% - 4.00% (2.28%) Non-performance spread 0.00% - 0.08% (0.03%) Option cost 0.00% - 5.02% (1.28%) Risk margin to reflect uncertainty 0.23% - 0.96% (0.34%) Morbidity risk margin 0.00% - 2.00% (0.07%) Derivatives: FIA embedded derivatives included in contractholder funds 3,235 Discounted cash flow Market value of option 0.00% - 32.54% SWAP rates 1.73% - 1.90% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Partial withdrawals 2.00% - 3.50% Non-performance spread 0.25% - 0.25% Option cost 0.18% - 16.61% Preferred shares reimbursement feature embedded derivative 16 Black Derman Toy model Credit Spread 3.81% Yield Volatility 20% Total financial liabilities at fair value $ 5,204
Changes in Fair Value of Financial Instruments - Assets	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three months ended March 31, 2020 and 2019 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended March 31, 2020 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 828 $ (2 ) $ (34 ) $ 147 $ — $ (158 ) $ (19 ) $ 762 $ (34 ) Commercial mortgage-backed securities 27 — (2 ) — — — — 25 (2 ) Corporates 1,292 — (73 ) 1 — (21 ) — 1,199 (73 ) Hybrids 10 — (1 ) — — (6 ) — 3 (1 ) Municipals 42 — (3 ) — — — — 39 (3 ) Residential mortgage-backed securities 546 — (17 ) 5 — (21 ) (6 ) 507 (17 ) Foreign Governments 18 — (2 ) — — — — 16 (2 ) Equity securities 1 — — — — — — 1 — Other invested assets: Available-for-sale embedded derivative 21 (4 ) — — — — — 17 — Credit linked note 25 — (2 ) — — — — 23 — Funds withheld for reinsurance receivables, at fair value 1 — — — — — (1 ) — — Total assets at Level 3 fair value $ 2,811 $ (6 ) $ (134 ) $ 153 $ — $ (206 ) $ (26 ) $ 2,592 (132 ) Liabilities Future policy benefits $ 1,953 $ (100 ) $ (3 ) $ — $ — $ 54 $ — $ 1,904 $ — FIA embedded derivatives, included in contractholder funds 3,235 279 — 140 (47 ) (304 ) — 3,303 — Preferred shares reimbursement feature embedded derivative 16 21 37 — Total liabilities at Level 3 fair value $ 5,204 $ 200 $ (3 ) $ 140 $ (47 ) $ (250 ) $ — $ 5,244 $ — (a) The net transfers out of Level 3 during the three months ended March 31, 2020 were exclusively to Level 2. Three months ended March 31, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 5 $ 114 $ — $ (31 ) $ (24 ) $ 508 Commercial mortgage-backed securities 67 — 2 — — (1 ) — 68 Corporates 1,231 (1 ) 24 — (21 ) (35 ) 11 1,209 Hybrids 10 — — — — — — 10 Municipals 37 — 1 — — — — 38 Residential mortgage-backed securities 614 — 16 7 — (18 ) — 619 Foreign Governments 16 — — — — — — 16 Equity securities 4 — 1 — — — 15 20 Other invested assets: Available-for-sale embedded derivative 14 2 — — — — — 2 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value 4 — — 5 — — (2 ) 7 Total assets at Level 3 fair value $ 2,466 $ 1 $ 49 $ 126 $ (21 ) $ (85 ) $ — $ 2,536 Liabilities Future policy benefits (FSRC) $ 725 $ 29 $ — $ — $ — $ 43 $ — $ 797 FIA embedded derivatives, included in contractholder funds 2,476 59 — 127 (33 ) 91 — 2,720 Preferred shares reimbursements feature embedded derivative 29 (2 ) — — — — — 27 Total liabilities at Level 3 fair value $ 3,230 $ 86 $ — $ 127 $ (33 ) $ 134 $ — $ 3,544 (a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2.
Changes in Fair Value of Financial Instruments - Liabilities	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three months ended March 31, 2020 and 2019 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended March 31, 2020 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 828 $ (2 ) $ (34 ) $ 147 $ — $ (158 ) $ (19 ) $ 762 $ (34 ) Commercial mortgage-backed securities 27 — (2 ) — — — — 25 (2 ) Corporates 1,292 — (73 ) 1 — (21 ) — 1,199 (73 ) Hybrids 10 — (1 ) — — (6 ) — 3 (1 ) Municipals 42 — (3 ) — — — — 39 (3 ) Residential mortgage-backed securities 546 — (17 ) 5 — (21 ) (6 ) 507 (17 ) Foreign Governments 18 — (2 ) — — — — 16 (2 ) Equity securities 1 — — — — — — 1 — Other invested assets: Available-for-sale embedded derivative 21 (4 ) — — — — — 17 — Credit linked note 25 — (2 ) — — — — 23 — Funds withheld for reinsurance receivables, at fair value 1 — — — — — (1 ) — — Total assets at Level 3 fair value $ 2,811 $ (6 ) $ (134 ) $ 153 $ — $ (206 ) $ (26 ) $ 2,592 (132 ) Liabilities Future policy benefits $ 1,953 $ (100 ) $ (3 ) $ — $ — $ 54 $ — $ 1,904 $ — FIA embedded derivatives, included in contractholder funds 3,235 279 — 140 (47 ) (304 ) — 3,303 — Preferred shares reimbursement feature embedded derivative 16 21 37 — Total liabilities at Level 3 fair value $ 5,204 $ 200 $ (3 ) $ 140 $ (47 ) $ (250 ) $ — $ 5,244 $ — (a) The net transfers out of Level 3 during the three months ended March 31, 2020 were exclusively to Level 2. Three months ended March 31, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 5 $ 114 $ — $ (31 ) $ (24 ) $ 508 Commercial mortgage-backed securities 67 — 2 — — (1 ) — 68 Corporates 1,231 (1 ) 24 — (21 ) (35 ) 11 1,209 Hybrids 10 — — — — — — 10 Municipals 37 — 1 — — — — 38 Residential mortgage-backed securities 614 — 16 7 — (18 ) — 619 Foreign Governments 16 — — — — — — 16 Equity securities 4 — 1 — — — 15 20 Other invested assets: Available-for-sale embedded derivative 14 2 — — — — — 2 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value 4 — — 5 — — (2 ) 7 Total assets at Level 3 fair value $ 2,466 $ 1 $ 49 $ 126 $ (21 ) $ (85 ) $ — $ 2,536 Liabilities Future policy benefits (FSRC) $ 725 $ 29 $ — $ — $ — $ 43 $ — $ 797 FIA embedded derivatives, included in contractholder funds 2,476 59 — 127 (33 ) 91 — 2,720 Preferred shares reimbursements feature embedded derivative 29 (2 ) — — — — — 27 Total liabilities at Level 3 fair value $ 3,230 $ 86 $ — $ 127 $ (33 ) $ 134 $ — $ 3,544 (a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2.
Schedule of Net Asset Value	The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2019 Form 10-K. Carrying Value After Measurement March 31, 2020 December 31, 2019 Equity securities $ — $ 69 Limited partnership investment, included in other invested assets 1,065 1,010
Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class	or investments for which NAV is used as a practical expedient for fair value, the Company does not have any significant restrictions in their ability to liquidate their positions in these investments, other than obtaining general partner approval, nor does the Company believe it is probable a price less than NAV would be received in the event of a liquidation. Equity method investments are reported on a lag of up to three months for investee information not received sufficiently timely. For the quarter ended March 31, 2020, the Company received updated NAVs on two investments reported on a lag that showed a decline in valuation of $20 which will be reported in the next quarter period end.

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Information Regarding Intangible Assets, VOBA and DAC	A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows: VOBA DAC DSI Total Balance at December 31, 2019 $ 593 $ 630 $ 232 $ 1,455 Deferrals — 106 27 133 Amortization 19 25 12 56 Interest 4 5 1 10 Unlocking (5 ) (1 ) 1 (5 ) Adjustment for net unrealized investment (gains) losses 262 79 39 380 Balance at March 31, 2020 $ 873 $ 844 $ 312 $ 2,029 VOBA DAC DSI Total Balance at December 31, 2018 $ 866 $ 344 $ 149 $ 1,359 Deferrals — 91 35 126 Amortization (31 ) (3 ) (2 ) (36 ) Interest 4 2 1 7 Unlocking — — — — Adjustment for net unrealized investment (gains) losses (35 ) — — (35 ) Balance at March 31, 2019 $ 804 $ 434 $ 183 $ 1,421 Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01% . The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of March 31, 2020 and 2019 , the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $155 and $40 , respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $9 and $5 , respectively, and the DSI balance included net unrealized investment (gains) losses of $10 and $2 , respectively.
Estimated Amortization Expense for VOBA in Future Fiscal Periods	Estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year 2020 63 2021 86 2022 83 2023 74 2024 66 Thereafter 347

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Debt	The interest expense for the three months ended March 31, 2020 and 2019 was $8 and $8 , respectively.

Equity (Tables)

Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Dividends Declared	The Company declared the following cash dividend to its common shareholders during the three months ended March 31, 2020 . Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid February 26, 2020 March 30, 2020 March 16, 2020 222,119 $0.01 $2 On May 6, 2020, the Company's Board of Directors will declare a quarterly cash dividend of $0.01 per share. The dividend will be paid on June 8, 2020 to shareholders of record as of May 26, 2020. The Company declared the following cash dividend to its common shareholders during the three months ended March 31, 2019 . Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid February 27, 2019 April 1, 2019 March 18, 2019 221,661 $0.01 $2 The Company declared the following dividends to its preferred shareholders during the three months ended March 31, 2020 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 31, 2020 April 1, 2020 March 15, 2020 321 Paid in kind $— 6 Series B Preferred Shares March 31, 2020 April 1, 2020 March 15, 2020 117 Paid in kind $— 2

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Summary of Unfunded Commitments	summary of unfunded commitments by invested asset class are included below: March 31, 2020 Asset Type Other invested assets $ 1,252 Fixed maturity securities, available-for-sale 111 Other assets $ 71 Residential mortgage loans 18 Total $ 1,452 As of March 31, 2020 , the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

Reinsurance (Tables)

Reinsurance (Tables)	3 Months Ended
	Mar. 31, 2020
Reinsurance Disclosures [Abstract]
Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes	The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the three months ended March 31, 2020 and 2019 were as follows: Three months ended March 31, 2020 March 31, 2019 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct 50 130 57 372 Assumed — (115 ) — 20 Ceded (40 ) (56 ) (41 ) (53 ) Net 10 (41 ) 16 339

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Summary of Basic and Diluted EPS	The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands): Three months ended March 31, 2020 March 31, 2019 Net income (loss) $ (338 ) $ 171 Less Preferred stock dividend 8 8 Net income (loss) available to common shares (346 ) 163 Weighted-average common shares outstanding - basic 213,155 219,646 Dilutive effect of unvested restricted stock — 36 Weighted-average shares outstanding - diluted 213,155 219,682 Net income (loss) per common share: Basic $ (1.62 ) $ 0.74 Diluted $ (1.62 ) $ 0.74

Basis of Presentation and Nat_2

Basis of Presentation and Nature of Business - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Goodwill	$ 467	$ 467

Significant Accounting Polici_3

Significant Accounting Policies and Practices (Details)	3 Months Ended
	Mar. 31, 2020
Condensed Balance Sheet Statements, Captions [Line Items]
Document Period End Date	Mar. 31, 2020

Significant Risks and Uncerta_2

Significant Risks and Uncertainties - Narrative (Details) $ in Millions	Sep. 30, 2019USD ($)	Mar. 31, 2020USD ($)issuer	Dec. 31, 2019USD ($)
Concentration Risk [Line Items]
Exposure of FGL's invested assets		10.00%
Number of issuers in investment | issuer		86
Wilton Reassurance Company
Concentration Risk [Line Items]
Net amount recoverable	$ 1,507
Kubera Reassurance Company [Member]
Concentration Risk [Line Items]
Net amount recoverable	$ 835
All Financial Instruments
Concentration Risk [Line Items]
FGL's investment securities in the banking industry		$ 2,216	$ 2,414
Exposure of FGL's invested assets		9.00%	9.00%
Single Issuer
Concentration Risk [Line Items]
FGL's investment securities in the banking industry		$ 123	$ 132
Exposure of FGL's invested assets		1.00%	1.00%
Banking Industry | All Financial Instruments
Concentration Risk [Line Items]
Investment securities held by subsidiaries subject to specialized industry accounting principles, amortized cost		$ 2,270	$ 2,325
Minimum
Concentration Risk [Line Items]
Exposure of FGL's invested assets			10.00%
Top Ten Holdings [Member]
Concentration Risk [Line Items]
Exposure of FGL's invested assets		38.00%
Number of issuers in investment | issuer		101

Investments - Available-for-Sa

Investments - Available-for-Sale Securities Table (Details) $ in Millions	Mar. 31, 2020USD ($)Security	Dec. 31, 2019USD ($)Security
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	$ 22,836	$ 22,914
Debt Securities, Available-for-sale, Allowance for Credit Loss	(44)	0
Available-for sale securities
Gross Unrealized Gains	503	979
Gross Unrealized Losses	(2,155)	(167)
Fair Value	21,140	23,726
Carrying Value	21,140	23,726
Equity Securities, Amortized Cost Basis	1,052	1,069
Financing Receivable, Allowance for Credit Loss	(56)
Investments, Cost or Amortized Cost	27,546	26,892
Investments, Accumulated Gross Unrealized Gain, before Tax	517	1,259
Investments, Accumulated Gross Unrealized Loss, before Tax	2,504	197
Investments, Fair Value Disclosure	25,526	27,955
Equity Securities, Accumulated Gross Unrealized Gain, before Tax	1	19
Equity Securities, Accumulated Gross Unrealized Loss, before tax	(138)	(17)
Equity Securities, Fair Value	915	1,071
Equity Securities, Carrying Value	915	1,071
Derivative investments
Amortized Cost	380	336
Gross Unrealized Gains	13	261
Gross Unrealized Losses	(205)	(10)
Fair Value	188	587
Carrying Value	188	587
Commercial mortgage loans
Loans and Leases Receivable, Net Amount	1,769	1,267
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	1,721	3,500
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(494)	(123)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	12,528	5,674
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ (2,139)	$ (167)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	1,365	290
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	294	446
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Security	1,659	736
Investments	$ 25,503	$ 27,954
Asset-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	5,785	5,720
Debt Securities, Available-for-sale, Allowance for Credit Loss	(17)	0
Available-for sale securities
Gross Unrealized Gains	26	51
Gross Unrealized Losses	(849)	(77)
Fair Value	4,945	5,694
Carrying Value	4,945	5,694
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	1,322	2,453
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(325)	(65)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	4,194	3,172
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(843)	(77)
Commercial mortgage-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	2,848	2,788
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	0
Available-for sale securities
Gross Unrealized Gains	16	140
Gross Unrealized Losses	(383)	(6)
Fair Value	2,481	2,922
Carrying Value	2,481	2,922
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	13	16
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(5)	(2)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	2,086	248
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(383)	(6)
Corporates
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	10,898	11,051
Debt Securities, Available-for-sale, Allowance for Credit Loss	(21)	0
Available-for sale securities
Gross Unrealized Gains	366	618
Gross Unrealized Losses	(792)	(72)
Fair Value	10,451	11,597
Carrying Value	10,451	11,597
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	239	804
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(144)	(47)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	4,930	1,834
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(788)	(72)
Equity securities
Available-for sale securities
Financing Receivable, Allowance for Credit Loss
Derivative Instruments
Available-for sale securities
Financing Receivable, Allowance for Credit Loss
Hybrids
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	976	983
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	0
Available-for sale securities
Gross Unrealized Gains	5	48
Gross Unrealized Losses	(90)	(4)
Fair Value	891	1,027
Carrying Value	891	1,027
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	31	60
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(11)	(3)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	700	83
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(90)	(4)
Municipals
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,270	1,284
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	0
Available-for sale securities
Gross Unrealized Gains	63	64
Gross Unrealized Losses	(15)	(5)
Fair Value	1,318	1,343
Carrying Value	1,318	1,343
Residential mortgage-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	884	917
Debt Securities, Available-for-sale, Allowance for Credit Loss	(6)	0
Available-for sale securities
Gross Unrealized Gains	17	40
Gross Unrealized Losses	(25)	(3)
Fair Value	870	954
Carrying Value	870	954
U.S. Government
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	40	33
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	0
Available-for sale securities
Gross Unrealized Gains	3	1
Gross Unrealized Losses	0	0
Fair Value	43	34
Carrying Value	43	34
Total investments
Available-for-sale securities, Fair Value, 12 months or longer		0
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		0
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value		6
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss		0
Foreign Governments
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	135	138
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	0
Available-for sale securities
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	7	17
Gross Unrealized Losses	(1)	0
Fair Value	141	155
Carrying Value	141	155
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	0
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	33
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(1)
Other invested assets
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,497	1,306
Available-for sale securities
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(6)	(3)
Fair Value	1,479	1,288
Carrying Value	1,491	1,303
Financing Receivable, Allowance for Credit Loss
Municipals
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	51	60
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(3)	(3)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	374	183
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(15)	(5)
Residential mortgage-backed securities
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	65	107
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(6)	(3)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	211	148
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(19)	(3)
Commercial Portfolio Segment [Member]
Available-for sale securities
Financing Receivable, Allowance for Credit Loss	(1)	(1)
Commercial mortgage loans
Investment, Commercial Mortgage Loans, Amortized Cost	488	422
Investments, Commercial Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Investments, Commercial Mortgage Loans, Accumulated Gross Unrealized Loss before Tax	0	0
Investments, Commercial Mortgage Loans, Fair Value Disclosure	507	435
Loans and Leases Receivable, Net Amount	487	422
Residential Portfolio Segment [Member]
Available-for sale securities
Financing Receivable, Allowance for Credit Loss	(11)	(7)
Commercial mortgage loans
Loans and Leases Receivable, Net Amount	1,282	845
Investment, Residential Mortgage Loans, Amortized Cost	1,293	845
Investments, Residential Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Residential mortgage loans	$ 1,297	$ 848

Investments - Credit Impairment

Investments - Credit Impairment Loss Type (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
Schedule of Investments [Line Items]
Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Including Credit Impairments	$ (2)
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Change in Status	0
Other than temporary impairment, non-credit losses recognized in OCI	0
Asset Backed Securities and Corporate Securities [Member]
Schedule of Investments [Line Items]
Amortized cost	1
Fair value	$ 1

Investments - Amortized Cost a

Investments - Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Document Period End Date	Mar. 31, 2020
Equity Securities, Amortized Cost Basis	$ 1,052	$ 1,069
Due in one year or less, Amortized Cost	84
Due after one year through five years, Amortized Cost	915
Due after five years through ten years, Amortized Cost	1,942
Due after ten years, Amortized Cost	10,378
Subtotal, Amortized Cost	13,319
Other securities which provide for periodic payments, Amortized Cost	9,517
Total fixed maturity available-for-sale securities, Amortized Cost	22,836
Due in one year or less, Fair Value	80
Due after one year through five years, Fair Value	870
Due after five years through ten years, Fair Value	1,872
Due after ten years, Fair Value	10,022
Subtotal, Fair Value	12,844
Other securities which provide for periodic payments, Fair Value	8,296
Total fixed maturity available-for-sale securities, Fair Value	21,140
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	5,785
Other securities which provide for periodic payments, Fair Value	4,945
Commercial mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	2,848
Other securities which provide for periodic payments, Fair Value	2,481
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	884
Other securities which provide for periodic payments, Fair Value	$ 870

Investments - Fair Value and G

Investments - Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details)	3 Months Ended
	Mar. 31, 2020USD ($)Security	Dec. 31, 2019USD ($)Security
Debt Securities, Available-for-sale [Line Items]
Document Period End Date	Mar. 31, 2020
Available-for-sale securities, Fair Value, Less than 12 months	$ 10,807,000,000	$ 2,174,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1,645,000,000)	(44,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	1,721,000,000	3,500,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(494,000,000)	(123,000,000)
Available-for-sale securities, Fair Value, Total	12,528,000,000	5,674,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (2,139,000,000)	$ (167,000,000)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	1,365	290
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	294	446
Total number of available-for-sale securities in an unrealized loss position | Security	1,659	736
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Unrealized Losses Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income		$ 0
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 2,872,000,000	719,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(518,000,000)	(12,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	1,322,000,000	2,453,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(325,000,000)	(65,000,000)
Available-for-sale securities, Fair Value, Total	4,194,000,000	3,172,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(843,000,000)	(77,000,000)
Commercial mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	2,073,000,000	232,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(378,000,000)	(4,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	13,000,000	16,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(5,000,000)	(2,000,000)
Available-for-sale securities, Fair Value, Total	2,086,000,000	248,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(383,000,000)	(6,000,000)
Corporates
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	4,691,000,000	1,030,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(644,000,000)	(25,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	239,000,000	804,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(144,000,000)	(47,000,000)
Available-for-sale securities, Fair Value, Total	4,930,000,000	1,834,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(788,000,000)	(72,000,000)
Hybrids
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	669,000,000	23,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(79,000,000)	(1,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	31,000,000	60,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(11,000,000)	(3,000,000)
Available-for-sale securities, Fair Value, Total	700,000,000	83,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(90,000,000)	(4,000,000)
Municipals
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	323,000,000	123,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(12,000,000)	(2,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	51,000,000	60,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(3,000,000)	(3,000,000)
Available-for-sale securities, Fair Value, Total	374,000,000	183,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(15,000,000)	(5,000,000)
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	146,000,000	41,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(13,000,000)	0
Available-for-sale securities, Fair Value, 12 months or longer	65,000,000	107,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(6,000,000)	(3,000,000)
Available-for-sale securities, Fair Value, Total	211,000,000	148,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(19,000,000)	(3,000,000)
U.S. Government
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months		6,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		0
Available-for-sale securities, Fair Value, 12 months or longer		0
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer		0
Available-for-sale securities, Fair Value, Total		6,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total		$ 0
Foreign Governments
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	33,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	0
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	0
Available-for-sale securities, Fair Value, Total	33,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (1,000,000)

Investments - Reconciliation o

Investments - Reconciliation of Other than Temporary Impairment on Fixed Maturity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]
Document Period End Date	Mar. 31, 2020
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Balance at the beginning of the period		$ 0
Increases attributable to credit losses on securities:
OTTI was previously recognized		0
OTTI was not previously recognized		0
Balance at the end of the period		$ 0

Investments - Other-than-Tempo

Investments - Other-than-Temporary Impairments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Schedule of Investments [Line Items]
Document Period End Date	Mar. 31, 2020
Total other-than-temporary impairments		$ (2)
Other than Temporary Impairment Losses, Investments	$ 0	2
Corporates
Schedule of Investments [Line Items]
Total other-than-temporary impairments		$ (2)

Investments - Schedule of Comm

Investments - Schedule of Commercial Mortgage Loan Investment (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)loan	Dec. 31, 2019USD ($)loan
Schedule of Investments [Line Items]
Document Period End Date	Mar. 31, 2020
Impaired loans, number | loan	0	0
Commercial mortgage loans, % of total	100.00%	100.00%
Loans and Leases Receivable, Gross	$ 488	$ 422
Loans Receivable, Gross, Residential, Mortgage		422
Loans and Leases Receivable, Net Amount	$ 1,769	$ 1,267
Hotel
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	4.00%	5.00%
Loans and Leases Receivable, Gross	$ 21	$ 21
Industrial - General
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	8.00%	9.00%
Loans and Leases Receivable, Gross	$ 37	$ 37
Industrial - Warehouse
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	4.00%	4.00%
Loans and Leases Receivable, Gross	$ 20	$ 20
Multifamily
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	25.00%	13.00%
Loans and Leases Receivable, Gross	$ 121	$ 54
Office
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	29.00%	34.00%
Loans and Leases Receivable, Gross	$ 142	$ 143
Retail
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	30.00%	35.00%
Loans and Leases Receivable, Gross	$ 147	$ 147
LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	58.00%	83.00%
Loans Receivable, Gross, Residential, Mortgage	$ 284	$ 352
LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	33.00%	17.00%
Loans Receivable, Gross, Residential, Mortgage	$ 159	$ 70
LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	9.00%
Loans Receivable, Gross, Residential, Mortgage	$ 44
East North Central
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	13.00%	15.00%
Loans and Leases Receivable, Gross	$ 64	$ 64
East South Central
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	11.00%	5.00%
Loans and Leases Receivable, Gross	$ 53	$ 19
Middle Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	16.00%	18.00%
Loans and Leases Receivable, Gross	$ 77	$ 77
Mountain
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	10.00%	12.00%
Loans and Leases Receivable, Gross	$ 51	$ 51
New England
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	1.00%	1.00%
Loans and Leases Receivable, Gross	$ 4	$ 4
Pacific
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	23.00%	27.00%
Loans and Leases Receivable, Gross	$ 112	$ 113
South Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	11.00%	13.00%
Loans and Leases Receivable, Gross	$ 55	$ 56
West North Central
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	3.00%	3.00%
Loans and Leases Receivable, Gross	$ 13	$ 13
West South Central
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	12.00%	6.00%
Loans and Leases Receivable, Gross	$ 59	$ 25
Greater than 1.25
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	481	416
Greater than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	278	346
Greater than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	159	70
Greater than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	44
Greater than 1.00 but less than 1.25
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	6	6
Greater than 1.00 but less than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	6	6
Greater than 1.00 but less than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	0	$ 0
Greater than 1.00 but less than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 0
Fair Value
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	100.00%	100.00%
Loans Receivable, Gross, Residential, Mortgage	$ 507	$ 435
Fair Value | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	58.00%	83.00%
Loans Receivable, Gross, Residential, Mortgage	$ 295	$ 363
Fair Value | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	33.00%	17.00%
Loans Receivable, Gross, Residential, Mortgage	$ 166	$ 72
Fair Value | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	9.00%
Loans Receivable, Gross, Residential, Mortgage	$ 46
Commercial Portfolio Segment [Member]
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	100.00%	100.00%
Loans and Leases Receivable, Gross	$ 488	$ 422
Loans Receivable, Gross, Residential, Mortgage	487
Allowance for loan loss	(1)	0
Loans and Leases Receivable, Net Amount	$ 487	$ 422

Investments - Net Investment I

Investments - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Schedule of Investments [Line Items]
Document Period End Date	Mar. 31, 2020
Gross investment income	$ 350	$ 317
Investment expense	(33)	(28)
Net investment income	317	289
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	258	265
Equity securities
Schedule of Investments [Line Items]
Gross investment income	14	21
Commercial mortgage loans
Schedule of Investments [Line Items]
Gross investment income	21	7
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	4	3
Other investments
Schedule of Investments [Line Items]
Gross investment income	6	5
Funds Withheld [Member]
Schedule of Investments [Line Items]
Gross investment income	22	8
Limited Partnership [Member]
Schedule of Investments [Line Items]
Gross investment income	$ 25	$ 8

Investments - Net Investment G

Investments - Net Investment Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Gain (Loss) on Securities [Line Items]
Document Period End Date	Mar. 31, 2020
Net realized losses on fixed maturity available-for-sale securities	$ 21	$ (3)
Realized gains on equity securities	(135)	78
Change in fair value of other derivatives and embedded derivatives	(4)	3
Realized losses on other invested assets	(7)	1
Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)	(48)	0
Realized gains (losses) on certain derivative instruments	38	(26)
Unrealized gains (losses) on certain derivative instruments	(396)	190
Derivative, Gain (Loss) on Derivative, Net	(161)	(3)
Change In Fair Value Derivatives, Including Other Derivatives	(523)	164
Realized gains (losses) on hedging derivatives and reinsurance-related embedded derivatives	(523)	164
Net investment gains (losses)	$ (692)	$ 240

Investments - Narrative (Detai

Investments - Narrative (Details)	3 Months Ended
	Mar. 31, 2020USD ($)loan	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)loan	Jun. 30, 2015USD ($)
Debt Securities, Available-for-sale [Line Items]
Commercial Mortgage Receivable, Percentage of Total Investments	2.00%
Non-income producing investment fair value	$ 0
FHLB collateral pledged	1,472,000,000		$ 1,472,000,000
Other than temporary impairment credit losses recognized in earnings, including credit impairments		$ 2,000,000
Other than temporary impairment credit losses recognized in earnings, reductions, change in status		0
Amortized cost	22,836,000,000		22,914,000,000
Fair Value	21,140,000,000		$ 23,726,000,000
Other than temporary impairment, non-credit losses recognized in OCI		0
Realized gains (losses) on other invested assets	$ (7,000,000)	1,000,000
Impaired loans, number | loan	0		0
Unrealized Gain (Loss) on Investments	$ (2,115,000,000)	779,000,000
Residential Mortgage Receivable, Percentage of Total Investments	5.00%		3.00%
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Unrealized Gain Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income			$ 0
Unrealized losses related to non-credit portion of OTTI included in AOCI			0
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized cost	$ 884,000,000		917,000,000
Fair Value	870,000,000		954,000,000
Available-for-sale Securities
Debt Securities, Available-for-sale [Line Items]
Assets held by insurance regulators	16,337,000,000		$ 17,591,000,000
Proceeds from available-for-sale investments, sold, matured or repaid:	$ 845,000,000	962,000,000
Commercial mortgage loans
Debt Securities, Available-for-sale [Line Items]
Loan to value, threshold	75.00%
Total fixed maturities | Available-for-sale Securities
Debt Securities, Available-for-sale [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:	$ 462,000,000	474,000,000
Gain on sale of investments	16,000,000	5,000,000
Loss on sale of investments	(3,000,000)	$ (10,000,000)
Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Unfunded investment commitment	1,452,000,000
Crescent Capital BDC Inc. | Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Unfunded investment commitment				$ 83,000,000
Golub Capital Partners 10, L.P. [Member] | Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Unfunded investment commitment	1,066,000,000
Other Investments	$ 1,252,000,000

Investments Impact of Adoption

Investments Impact of Adoption of New Accounting Pronouncement (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net investment gains (losses)	$ (692)	$ 240
Gain (Loss) on Sale of Equity Investments	(135)	78
Unrealized Gain (Loss) on Investments	$ (2,115)	$ 779

Investments Schedule of Residen

Investments Schedule of Residential Mortgage Loan Investment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Document Period End Date	Mar. 31, 2020
Loans Receivable, Gross, Residential, Mortgage		$ 422
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
FLORIDA
Loans Receivable, Gross, Residential, Mortgage	$ 236	$ 167
Residential Mortgage Receivable, Percentage of Total	19.00%	20.00%
ILLINOIS
Loans Receivable, Gross, Residential, Mortgage	$ 206	$ 141
Residential Mortgage Receivable, Percentage of Total	16.00%	17.00%
NEW JERSEY
Loans Receivable, Gross, Residential, Mortgage	$ 122	$ 76
Residential Mortgage Receivable, Percentage of Total	10.00%
All Other States [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 704	$ 447
Residential Mortgage Receivable, Percentage of Total	56.00%	54.00%
Total Mortgage Loans [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 1,268	$ 831
Residential Portfolio Segment [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 1,293	$ 845
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Loans and Leases Receivable, Allowance	$ 11	$ 0
Financing Receivable, Allowance For Credit Loss, Percent Of Total	0.00%	0.00%
Loans Receivable, Net, Residential, Mortgage	$ 1,282	$ 845
Performing [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 1,282	$ 843
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Non-performing [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 11	$ 2
Residential Mortgage Receivable, Percentage of Total	0.00%	0.00%
Maximum | All Other States [Member]
Residential Mortgage Receivable, Percentage of Total		9.00%

Investments - Available for Sal

Investments - Available for Sale Allowance for Credit Loss (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	$ 0
For credit losses on securities for which losses were not previously recorded	(45)
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	(44)
Asset-backed securities
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	0
For credit losses on securities for which losses were not previously recorded	(17)
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	(17)
Commercial mortgage-backed securities
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	0
For credit losses on securities for which losses were not previously recorded	0
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	0
Corporates
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	0
For credit losses on securities for which losses were not previously recorded	(22)
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	(21)
Hybrids
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	0
For credit losses on securities for which losses were not previously recorded	0
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	0
Municipals
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	0
For credit losses on securities for which losses were not previously recorded	0
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	0
Residential mortgage-backed securities
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	0
For credit losses on securities for which losses were not previously recorded	(6)
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	(6)
U.S. Government
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	0
For credit losses on securities for which losses were not previously recorded	0
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	0
Foreign Governments
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	0
For credit losses on securities for which losses were not previously recorded	0
For initial credit losses on purchased securities accounted for as PCD financial assets	0
Additions (reductions) in allowance recorded on previously impaired securities	0
For securities sold during the period	0
For securities intended/required to be sold prior to recovery of amortized cost basis	0
Balance at End of Period	$ 0

Investments - Credit Quality In

Investments - Credit Quality Indicators (Details) $ in Millions	Mar. 31, 2020USD ($)
Residential Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	$ 316
2019	780
2018	81
2017	48
2016	65
Prior	3
Total	1,293
Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	68
2019	0
2018	6
2017	0
2016	11
Prior	403
Total	488
Current (less than 30 days past due) | Residential Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	304
2019	671
2018	73
2017	48
2016	63
Prior	3
Total	1,162
Current (less than 30 days past due) | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	68
2019	0
2018	6
2017	0
2016	11
Prior	403
Total	488
30-89 days past due | Residential Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	12
2019	100
2018	6
2017	0
2016	2
Prior	0
Total	120
30-89 days past due | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	0
Total	0
Over 90 days past due | Residential Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0
2019	9
2018	2
2017	0
2016	0
Prior	0
Total	11
Over 90 days past due | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	0
Total	0
Less than 50% | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0
2019	0
2018	6
2017	0
2016	0
Prior	278
Total	284
50% to 60% | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	34
2019	0
2018	0
2017	0
2016	0
Prior	125
Total	159
60% to 75% | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	34
2019	0
2018	0
2017	0
2016	11
Prior	0
Total	45
Greater than 1.25x | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	68
2019	0
2018	6
2017	0
2016	11
Prior	397
Total	482
1.00x - 1.25x | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	6
Total	6
Less than 1.00x | Commercial Portfolio Segment [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	0
Total	$ 0

Investments - Financing Receiva

Investments - Financing Receivable Allowance for Credit Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Financing Receivable, Allowance for Credit Loss [Roll Forward]
(Reversal of) provision for loan losses	$ (48)	$ 0
Ending balance	56
Residential Portfolio Segment [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	7
(Reversal of) provision for loan losses	4
Ending balance	11
Commercial Portfolio Segment [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	1
(Reversal of) provision for loan losses	0
Ending balance	1
Residential And Commercial Portfolio Segment [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	8
(Reversal of) provision for loan losses	4
Ending balance	$ 12

Investments - Loans Past Due (D

Investments - Loans Past Due (Details) $ in Millions	Mar. 31, 2020USD ($)
Financing Receivable, Past Due [Line Items]
Total loans that are 90 days or more past due and still accruing	$ 11
Residential Portfolio Segment [Member]
Financing Receivable, Past Due [Line Items]
Total loans that are 90 days or more past due and still accruing	11
Commercial Portfolio Segment [Member]
Financing Receivable, Past Due [Line Items]
Total loans that are 90 days or more past due and still accruing	$ 0

Derivative Financial Instrume_3

Derivative Financial Instruments - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Total asset derivatives	$ 206	$ 611
Total liability derivatives	3,324	3,284
Call options | Derivative Instruments
Derivative [Line Items]
Total asset derivatives	188	587
Other derivatives and embedded derivatives | Other invested assets
Derivative [Line Items]
Total asset derivatives	17	21
FIA embedded derivative | Contractholder funds
Derivative [Line Items]
Total liability derivatives	3,303	3,235
Preferred shares reimbursement feature embedded derivative | Other Liabilities [Member]
Derivative [Line Items]
Total liability derivatives	$ 37	$ 16

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Change in Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	$ (161)	$ (3)
Change In Fair Value Of Derivatives	(523)	164
Call options | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	(360)	154
Futures contracts | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	0	8
Foreign Exchange Forward [Member] | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	2	2
Other derivatives and embedded derivatives | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	(4)	3
Reinsurance related embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	(161)	(3)
Preferred shares reimbursement feature embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	21	(2)
FIA embedded derivative
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	$ 68	$ 244

Derivative Financial Instrume_5

Derivative Financial Instruments - FGL's Exposure to Credit Loss on Call Options Held (Detail) - USD ($) $ in Millions	Sep. 30, 2019	Mar. 31, 2020	Dec. 31, 2019
Derivatives, Fair Value [Line Items]
Fair Value		$ 206	$ 611
Merrill Lynch
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/*/A+
Deutsche Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	BBB/A3/BBB+
Notional Amount		35	157
Fair Value		2	7
Collateral		1	7
Net Credit Risk		1	0
Morgan Stanley
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/A1/A+
Notional Amount		2,162	2,053
Fair Value		8	66
Collateral		9	65
Net Credit Risk		0	1
Barclay's Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/A1/A
Notional Amount		4,521	4,290
Fair Value		115	211
Collateral		110	193
Net Credit Risk		5	18
Canadian Imperial Bank of Commerce [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	AA/Aa2/A+
Notional Amount		2,727	2,691
Fair Value		31	106
Collateral		25	74
Net Credit Risk		6	32
Wells Fargo [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/A2/A-
Notional Amount		2,558	2,165
Fair Value		21	81
Collateral		26	80
Net Credit Risk		0	1
GOLDMAN SACH MTF [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A/A3/BBB+
Notional Amount		1,112	1,065
Fair Value		5	31
Collateral		3	27
Net Credit Risk		2	4
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivatives, Fair Value [Line Items]
Notional Amount		15,698	15,139
Fair Value		189	590
Collateral		174	489
Net Credit Risk		21	101
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Merrill Lynch
Derivatives, Fair Value [Line Items]
Notional Amount		2,583	2,718
Fair Value		7	88
Collateral		0	43
Net Credit Risk		$ 7	$ 45

Derivative Financial Instrume_6

Derivative Financial Instruments - Narrative (Details) $ in Millions	Nov. 30, 2017shares	Mar. 31, 2020USD ($)contract	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)contract	Dec. 31, 2018USD ($)	Jun. 16, 2014USD ($)
Derivative [Line Items]
Fair Value		$ 206		$ 611
Fair value of assets			$ 2,536		$ 2,466
Derivative, Gain (Loss) on Derivative, Net		$ (161)	(3)
Other derivatives and embedded derivatives
Derivative [Line Items]
Term of contract, term one		1 year
Term of contract, term two		2 years
Term of contract, term three		3 years
Term of contract, term four		5 years
Futures contracts
Derivative [Line Items]
Number of instruments held | contract		379,000,000		879,000,000
Collateral held		$ 4		$ 5
Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Fair Value		17		21
Derivative investments | Call options
Derivative [Line Items]
Fair Value		188		587
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		189		590
Collateral posted		174		489
Maximum amount of loss due to credit risk		21		101
Cash and Cash Equivalents | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Collateral posted		174		446
Other Investments Asset | Other invested assets
Derivative [Line Items]
Fixed maturities securities, available-for-sale, at fair value		29		29		$ 35
Merrill Lynch [Member] | Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		7		88
Collateral posted		0		43
Maximum amount of loss due to credit risk		$ 7		$ 45
Preferred Stock
Derivative [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years	5 years
Preferred stock dividend rate	10.00%
Series A Cumulative Preferred Stock [Member] | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	275,000
Series B Cumulative Preferred Stock [Member] | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	100,000
Net investment (losses) gains | Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		$ 2	2
Net investment (losses) gains | Other derivatives and embedded derivatives
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		(4)	3
Net investment (losses) gains | Call options
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		(360)	154
Net investment (losses) gains | Futures contracts
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		$ 0	$ 8

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Assets and Liabilities Carrying at Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 21,140	$ 23,726
Derivative investments, at fair value	188	587
Total financial assets at fair value	2,592	2,811
Funds withheld for reinsurance receivables, at fair value	2,050	2,172
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	776	969
Equity securities	365	387
Derivative investments, at fair value	0	0
Derivative Liability	2
Other invested assets		0
Total financial assets at fair value	1,734	1,997
Total financial liabilities at fair value	2	0
FHLB common stock	0	0
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Policy loans, included in other invested assets	0	0
Affiliated other invested assets	0	0
Bank Owned Life Insurance		0
Funds withheld for reinsurance receivables, at fair value		0
Total assets carried on balance sheet at amounts other than fair value	0	0
Investment contracts, included in contractholder funds	0	0
Debt	0	0
Total liabilities carried on balance sheet at amounts other than fair value	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
Equity securities	549	614
Derivative investments, at fair value	188	587
Derivative Liability	0
Other invested assets		0
Total financial assets at fair value	20,783	23,693
Total financial liabilities at fair value	(18)	33
FHLB common stock	65	62
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Policy loans, included in other invested assets	0	0
Affiliated other invested assets	0	0
Bank Owned Life Insurance		0
Funds withheld for reinsurance receivables, at fair value		0
Total assets carried on balance sheet at amounts other than fair value	65	62
Investment contracts, included in contractholder funds	0	0
Debt	537	578
Total liabilities carried on balance sheet at amounts other than fair value	537	578
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
Equity securities	1	1
Derivative investments, at fair value	0	0
Derivative Liability	0
Other invested assets		46
Total financial assets at fair value	2,592	2,811
Total financial liabilities at fair value	5,244	5,204
FHLB common stock	0	0
Commercial mortgage loans	507	435
Residential mortgage loans	1,297	848
Policy loans, included in other invested assets	19	14
Affiliated other invested assets	26	28
Bank Owned Life Insurance	264	129
Funds withheld for reinsurance receivables, at fair value		1
Total assets carried on balance sheet at amounts other than fair value	2,113	1,455
Investment contracts, included in contractholder funds	19,915	19,285
Debt	0	0
Total liabilities carried on balance sheet at amounts other than fair value	19,915	19,285
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	776	969
Equity securities	915	1,002
Derivative investments, at fair value	188	587
Derivative Liability	2
Other invested assets		46
Total financial assets at fair value	25,109	28,501
Total financial liabilities at fair value	5,228	5,237
FHLB common stock	65	62
Commercial mortgage loans	507	435
Residential mortgage loans	1,297	848
Policy loans, included in other invested assets	19	14
Affiliated other invested assets	26	28
Bank Owned Life Insurance	264	129
Funds withheld for reinsurance receivables, at fair value		1
Total assets carried on balance sheet at amounts other than fair value	2,178	1,517
Investment contracts, included in contractholder funds	19,915	19,285
Debt	537	578
Total liabilities carried on balance sheet at amounts other than fair value	20,452	19,863
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	776	969
Equity securities	915	1,002
Derivative investments, at fair value	188	587
Derivative Liability	2
Other invested assets		46
Total financial assets at fair value	25,109	28,501
Total financial liabilities at fair value	5,228	5,237
FHLB common stock	65	62
Commercial mortgage loans	487	422
Residential mortgage loans	1,282	845
Policy loans, included in other invested assets	29	28
Affiliated other invested assets	28	28
Bank Owned Life Insurance	264	129
Funds withheld for reinsurance receivables, at fair value		1
Total assets carried on balance sheet at amounts other than fair value	2,155	1,515
Investment contracts, included in contractholder funds	22,923	22,449
Debt	543	542
Total liabilities carried on balance sheet at amounts other than fair value	23,466	22,991
Fixed indexed annuities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Fixed indexed annuities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Fixed indexed annuities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,303	3,235
Fixed indexed annuities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,303	3,235
Fixed indexed annuities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,303	3,235
Reinsurance related embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Reinsurance related embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	(18)	33
Reinsurance related embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Reinsurance related embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	(18)	33
Reinsurance related embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	(18)	33
Preferred shares reimbursement feature embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Preferred shares reimbursement feature embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Preferred shares reimbursement feature embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	37	16
Preferred shares reimbursement feature embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	37	16
Preferred shares reimbursement feature embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	37	16
Future Policy Benefits | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Future Policy Benefits | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Future Policy Benefits | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,904	1,953
Future Policy Benefits | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,904	1,953
Future Policy Benefits | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,904	1,953
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,945	5,694
Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,183	4,866
Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	762	828
Asset-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,945	5,694
Asset-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,945	5,694
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,481	2,922
Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,456	2,895
Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	25	27
Commercial mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,481	2,922
Commercial mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,481	2,922
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,451	11,597
Corporates | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Corporates | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	9,252	10,305
Corporates | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,199	1,292
Corporates | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,451	11,597
Corporates | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,451	11,597
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	891	1,027
Hybrids | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	267	299
Hybrids | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	621	718
Hybrids | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3	10
Hybrids | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	891	1,027
Hybrids | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	891	1,027
Municipals | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Municipals | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,279	1,301
Municipals | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	39	42
Municipals | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,318	1,343
Municipals | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,318	1,343
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	870	954
Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	363	408
Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	507	546
Residential mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	870	954
Residential mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	870	954
U.S. Government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	43	34
U.S. Government | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	37	28
U.S. Government | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	6	6
U.S. Government | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
U.S. Government | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	43	34
U.S. Government | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	43	34
Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	141	155
Foreign Governments | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Foreign Governments | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	125	137
Foreign Governments | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	16	18
Foreign Governments | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	141	155
Foreign Governments | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	141	155
Other invested assets | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	40
Other invested assets | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	40
Other invested assets | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	40
Funds withheld for reinsurance receivables, at fair value | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	289	314
Funds withheld for reinsurance receivables, at fair value | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,761	1,856
Funds withheld for reinsurance receivables, at fair value | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	1
Funds withheld for reinsurance receivables, at fair value | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,050	2,171
Funds withheld for reinsurance receivables, at fair value | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 2,050	$ 2,171

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 2,592,000,000	$ 2,811,000,000
Liabilities, fair value	5,244,000,000	5,204,000,000
Future Policy Benefit		1,953,000,000
Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	624,000,000	801,000,000
Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	25,000,000	27,000,000
Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	293,000,000	346,000,000
Market Approach | Municipals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	39,000,000	42,000,000
Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	500,000,000
Residential Mortage Backed securities		546,000,000
Market Approach | Foreign Governments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	16,000,000	18,000,000
Market Approach | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loan Recovery Value		1,000,000
Market Approach | Credit Linked Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	23,000,000
Loan Recovery Value		25,000,000
Third Parties | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	138,000,000	27,000,000
Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		946,000,000
Income Approach Valuation Technique | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		10,000,000
Black Scholes Model | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	17,000,000
Matrix Pricing Valuation | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	906,000,000
Matrix Pricing Valuation | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	3,000,000
Matrix Pricing Valuation | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	7,000,000
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	3,303,000,000	3,235,000,000
Preferred shares reimbursement feature embedded derivative | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 37,000,000	$ 16,000,000
Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Minimum | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	91.53%	98.65%
Minimum | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	82.38%	83.51%
Minimum | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.80%	104.72%
Minimum | Market Approach | Municipals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.01%	127.68%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Minimum | Market Approach | Foreign Governments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	102.02%	110.12%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		0.00%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	59.84%	98.58%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.00%	0.00%
Minimum | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Minimum | Option Cost | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option		0.00%
Minimum | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%
Minimum | Future Policy Benefits, Mortality Multiplier | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	80.00%
Minimum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%	0.00%
Fair value inputs, swap rates	0.52%	0.23%
Fair value inputs, mortality multiplier	80.00%	0.00%
Fair value inputs, surrender rates	0.50%	0.50%
Fair value inputs, non performance spread	0.25%	1.73%
Minimum | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.00%	2.00%
Minimum | Fixed indexed annuities | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	0.09%	80.00%
Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Maximum | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	112.18%	119.35%
Maximum | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	102.13%	106.73%
Maximum | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.80%	104.72%
Maximum | Market Approach | Municipals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.01%	127.68%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.20%	106.50%
Maximum | Market Approach | Foreign Governments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	102.85%	118.09%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		0.00%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	116.89%	119.44%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.17%	55.00%
Maximum | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	105.02%	99.43%
Maximum | Option Cost | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option		5.02%
Maximum | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	5.37%
Maximum | Future Policy Benefits, Mortality Multiplier | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	120.00%
Maximum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	26.37%	32.54%
Fair value inputs, swap rates	0.72%	0.96%
Fair value inputs, mortality multiplier	80.00%	2.00%
Fair value inputs, surrender rates	75.00%	75.00%
Fair value inputs, non performance spread	0.25%	1.90%
Maximum | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	3.50%	3.50%
Maximum | Fixed indexed annuities | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	16.61%	80.00%
Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Credit Spread	$ 0.0751	$ 0.0381
Yield Volatility	0.00%	20.00%
Risk Margin To Reflect Uncertainty		0.00%
Weighted Average | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	97.88%	102.02%
Weighted Average | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	95.47%	99.56%
Weighted Average | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.80%	104.72%
Weighted Average | Market Approach | Municipals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.01%	127.68%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.20%	106.28%
Weighted Average | Market Approach | Foreign Governments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	102.28%	112.61%
Weighted Average | Market Approach | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.00%	0.00%
Fair Value Input Recovery Rate		2.47%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		0.00%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	99.21%	105.06%
Weighted Average | Income Approach Valuation Technique | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Input Recovery Rate	2.33%
Weighted Average | Income Approach Valuation Technique | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	100.00%	100.00%
Weighted Average | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.07%	21.18%
Weighted Average | Matrix Pricing Valuation | Funds withheld for reinsurance liabilities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model		0.00%
Weighted Average | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	71.27%	35.96%
Weighted Average | Third Party Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.31%	126.82%
Weighted Average | Option Cost | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option		1.28%
Weighted Average | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	1.13%
Weighted Average | Future Policy Benefits, Mortality Multiplier | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	95.82%
Weighted Average | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	1.12%	3.64%
Fair value inputs, swap rates	0.62%	0.34%
Fair value inputs, mortality multiplier	80.00%	0.07%
Fair value inputs, surrender rates	5.66%	5.64%
Fair value inputs, non performance spread	0.25%	1.81%
Weighted Average | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.53%	2.53%
Weighted Average | Fixed indexed annuities | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	2.14%	80.00%
Insurance Subsidiary | Market Approach | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 1,000,000
Insurance Subsidiary | Income Approach Valuation Technique | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 1,000,000
Insurance Subsidiary | Income Approach Valuation Technique | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 21,000,000
Insurance Subsidiary | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Inputs, Other Loan Recoveries	84.49%	100.15%
Insurance Subsidiary | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Inputs, Other Loan Recoveries	119.30%	127.60%
FSRC | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 1,904,000,000

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Changes to Fair Value of Financial Instruments Level 3 (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	$ 0
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		$ 2,466
Assets, Total Gains (Losses) Included in Earnings		1
Assets, Total Gains (Losses) Included in AOCI		49
Assets, Purchases		126
Assets, Sales		21
Assets, Settlements		85
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		2,536
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	5,204	3,230
Available-for-sale Securities	21,140		$ 23,726
Liabilities, Total Gains (Losses) Included in Earnings	200	86
Liabilities, Total Gains (Losses) Included in AOCI	(3)	0
Liabilities, Purchases	140	127
Liabilities, Sales	47	33
Liabilities, Settlements	(250)	134
Liabilities, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	5,244	3,544
FIA embedded derivatives, included in contractholder funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	3,235	2,476
Liabilities, Total Gains (Losses) Included in Earnings	279	59
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	140	127
Liabilities, Sales	47	33
Liabilities, Settlements	304	(91)
Liabilities, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	3,303	2,720
Future Policy Benefits
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1,953	725
Liabilities, Total Gains (Losses) Included in Earnings	(100)	29
Liabilities, Total Gains (Losses) Included in AOCI	(3)	0
Liabilities, Purchases	0	0
Liabilities, Sales	0	0
Liabilities, Settlements	54	43
Liabilities, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	1,904	797
Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	(34)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	828	444
Assets, Total Gains (Losses) Included in Earnings	(2)	0
Assets, Total Gains (Losses) Included in AOCI	(34)	5
Assets, Purchases	147	114
Assets, Sales	0	0
Assets, Settlements	(158)	(31)
Assets, Net transfer In (Out) of Level 3	(19)	(24)
Balance at End of Period	762	508
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	4,945		5,694
Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	(2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	27	67
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	(2)	2
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	1
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	25	68
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	2,481		2,922
Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	(73)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1,292	1,231
Assets, Total Gains (Losses) Included in Earnings	0	(1)
Assets, Total Gains (Losses) Included in AOCI	(73)	24
Assets, Purchases	1	0
Assets, Sales	0	(21)
Assets, Settlements	(21)	(35)
Assets, Net transfer In (Out) of Level 3	0	11
Balance at End of Period	1,199	1,209
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	10,451		11,597
Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	(1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	10	10
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	(1)	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	(6)	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	3	10
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	891		1,027
Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	(3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	42	37
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	(3)	1
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	39	38
Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	(17)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	546	614
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	(17)	16
Assets, Purchases	5	7
Assets, Sales	0	0
Assets, Settlements	21	18
Assets, Net transfer In (Out) of Level 3	(6)	0
Balance at End of Period	507	619
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	870		954
Foreign Governments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	(2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	18	16
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	(2)	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	16	16
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	141		155
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	0
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1	4
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	1
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	15
Balance at End of Period	1	20
Available-for-sale embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	0
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	21	14
Assets, Total Gains (Losses) Included in Earnings	(4)	2
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	17	2
Funds withheld for reinsurance receivables, at fair value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	0
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1	4
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	0	5
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	(1)	(2)
Balance at End of Period	0	7
Total assets at level 3 [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	(132)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,811
Assets, Total Gains (Losses) Included in Earnings	(6)
Assets, Total Gains (Losses) Included in AOCI	(134)
Assets, Purchases	153
Assets, Sales	0
Assets, Settlements	206
Assets, Net transfer In (Out) of Level 3	(26)
Balance at End of Period	2,592
Affiliated Entity | Bank Loan Obligations [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	0
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	25	25
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	(2)	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	23	25
Fair Value | Asset-backed securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	4,945		5,694
Fair Value | Commercial mortgage-backed securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	2,481		2,922
Fair Value | Corporates
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	10,451		11,597
Fair Value | Hybrids
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	891		1,027
Fair Value | Municipals
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	1,318		1,343
Fair Value | Residential mortgage-backed securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	870		954
Fair Value | Foreign Governments
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	141		155
Fair Value | Funds withheld for reinsurance receivables, at fair value
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	2,050		2,171
Fair Value | Other invested assets
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	40
Fair Value | Fixed indexed annuities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	3,303		3,235
Fair Value | Preferred shares reimbursement feature embedded derivative
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	37		16
Fair Value | Preferred shares reimbursement feature embedded derivative | Preferred shares reimbursement feature embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Unrealized Gain (Loss) Included in Other Comprehensive Income (Loss)	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	37	27	$ 16	$ 29
Liabilities, Total Gains (Losses) Included in Earnings	21	(2)
Liabilities, Total Gains (Losses) Included in AOCI		0
Liabilities, Purchases		0
Liabilities, Sales		0
Liabilities, Settlements		0
Liabilities, Net transfer In (Out) of Level 3		$ 0

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - NAV (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure	$ 25,526	$ 27,955
Level 1
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	0	0
Level 2
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	0	0
Level 3
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	1,297	848
Fair Value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	1,297	848
Carrying Value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	$ 1,282	$ 845

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Narrative (Detail)	Nov. 30, 2017	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)$ / Contract	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings			$ 200,000,000	$ 86,000,000
Assets, net transfer in (out) of Level 3				0
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3			(19,000,000)	(24,000,000)
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3			0	0
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3			0	11,000,000
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3			0	0
States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3			0	0
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3			(6,000,000)	0
Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3			0	0
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Alternative Investment			0		$ 69,000,000
Assets, net transfer in (out) of Level 3			$ 0	$ 15,000,000
Income Approach Valuation Technique | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, strike price | $ / Contract			0
Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years		5 years
Preferred Stock, Dividend Rate, Percentage, Less Than Par			90.00%
Available-for-sale Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held by insurance regulators			$ 16,337,000,000		$ 17,591,000,000
FSRC and F&G Re [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Undiscounted Cash flows used in fair value measurement			$ (263,000,000)
Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty					0.00%
Maximum | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			112.18%		119.35%
Maximum | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			102.13%		106.73%
Maximum | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			100.80%		104.72%
Maximum | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			118.01%		127.68%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			103.20%		106.50%
Maximum | Market Approach | Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			102.85%		118.09%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices					0.00%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			0.00%		0.00%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			116.89%		119.44%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model			0.17%		55.00%
Maximum | Third Party Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			105.02%		99.43%
Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty					0.00%
Credit Spread			$ 0.0751		$ 0.0381
Yield Volatility			0.00%		20.00%
Weighted Average | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			97.88%		102.02%
Weighted Average | Market Approach | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			100.00%		0.00%
Fair Value Input Recovery Rate					2.47%
Weighted Average | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			95.47%		99.56%
Weighted Average | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			100.80%		104.72%
Weighted Average | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			118.01%		127.68%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			103.20%		106.28%
Weighted Average | Market Approach | Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			102.28%		112.61%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices					0.00%
Weighted Average | Income Approach Valuation Technique | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model			100.00%		100.00%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			0.00%		0.00%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			99.21%		105.06%
Weighted Average | Income Approach Valuation Technique | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Input Recovery Rate			2.33%
Weighted Average | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model			0.07%		21.18%
Weighted Average | Third Party Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			71.27%		35.96%
Weighted Average | Third Party Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			118.31%		126.82%
Weighted Average | Matrix Pricing Valuation | Funds withheld for reinsurance liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model					0.00%
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty					0.00%
Minimum | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			91.53%		98.65%
Minimum | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			82.38%		83.51%
Minimum | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			100.80%		104.72%
Minimum | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			118.01%		127.68%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			0.00%		0.00%
Minimum | Market Approach | Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			102.02%		110.12%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices					0.00%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			0.00%		0.00%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			59.84%		98.58%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model			0.00%		0.00%
Minimum | Third Party Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			0.00%		0.00%
Affiliated Entity | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Other Loan Recoveries			119.30%		127.60%
Affiliated Entity | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Other Loan Recoveries			84.49%		100.15%
Future Policy Benefits | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption			0.02
Fair value inputs, swap rates			55.00%
Fair value inputs, mortality multiplier			4.00%
Fair value inputs, non performance spread			5.00%
Risk Margin To Reflect Uncertainty			0.96%
Future Policy Benefits | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption			.0007
Fair value inputs, swap rates			21.06%
Fair value inputs, mortality multiplier			2.15%
Fair value inputs, non performance spread			1.34%
Risk Margin To Reflect Uncertainty			0.40%
Future Policy Benefits | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption			0
Fair value inputs, swap rates			0.50%
Fair value inputs, mortality multiplier			0.00%
Fair value inputs, non performance spread			0.00%
Risk Margin To Reflect Uncertainty			0.31%
Fixed indexed annuities | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option			26.37%		32.54%
Fair value inputs, swap rates			0.72%		0.96%
Fair value inputs, mortality multiplier			80.00%		2.00%
Fair value inputs, surrender rates			75.00%		75.00%
Fair value inputs, non performance spread			0.25%		1.90%
Fixed indexed annuities | Maximum | Partial Withdrawls
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates			3.50%		3.50%
Fixed indexed annuities | Maximum | Option Cost
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread			16.61%		80.00%
Fixed indexed annuities | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option			1.12%		3.64%
Fair value inputs, swap rates			0.62%		0.34%
Fair value inputs, mortality multiplier			80.00%		0.07%
Fair value inputs, surrender rates			5.66%		5.64%
Fair value inputs, non performance spread			0.25%		1.81%
Fixed indexed annuities | Weighted Average | Partial Withdrawls
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates			2.53%		2.53%
Fixed indexed annuities | Weighted Average | Option Cost
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread			2.14%		80.00%
Fixed indexed annuities | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option			0.00%		0.00%
Fair value inputs, swap rates			0.52%		0.23%
Fair value inputs, mortality multiplier			80.00%		0.00%
Fair value inputs, surrender rates			0.50%		0.50%
Fair value inputs, non performance spread			0.25%		1.73%
Fixed indexed annuities | Minimum | Partial Withdrawls
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates			2.00%		2.00%
Fixed indexed annuities | Minimum | Option Cost
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread			0.09%		80.00%
Private Equity Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Alternative Investment			$ 1,065,000,000		$ 1,010,000,000
Subsequent Event [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		$ 20,000,000

Intangible Assets - Schedule of

Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Millions	Jun. 30, 2019	Mar. 31, 2020	Dec. 31, 2019
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount		$ 2,029	$ 1,455
FGL [Member] | Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		12
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
FGL [Member] | Licensing Agreements [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount		$ 6

Intangible Assets - Summary of

Intangible Assets - Summary of Changes in Carrying Amounts of Intangible Assets Including DAC, VOBA , and DSI (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Deferred Sale Inducement Cost	$ 312	$ 183	$ 232	$ 149
VOBA
VOBA at beginning of period	593	866
Deferrals	0	0
Amortization	19	(31)
Interest	4	4
Unlocking	(5)	0
Adjustment for net unrealized investment (gains) losses	262	(35)
VOBA at end of period	873	804
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	39	0
Deferred Sales Inducement Cost, Unlocking Adjustment	1	0
Deferred Sales Inducement Cost, Amortization Expense, Accrued Interest	1	1
Deferred Sales Inducement Cost, Amortization Expense	12	(2)
Deferred Sale Inducement Cost, Capitalization	27	35
DAC
DAC at beginning of period	844	434	630	344
Deferrals	106	91
Amortization	25	(3)
Interest	5	2
Unlocking	(1)	0
Adjustment for net unrealized investment (gains) losses	79	0
DAC at end of period	844	434	630	344
Total
Total VOBA and DAC at beginning of period	2,029	1,421	$ 1,455	$ 1,359
Deferrals	133	126
Amortization	56	(36)
Unlocking	(5)	0
Adjustment for net unrealized investment (gains) losses	380	(35)
Interest	$ 10	$ 7
Document Period End Date	Mar. 31, 2020

Intangible Assets - Definite Li

Intangible Assets - Definite Lived Intangible Assets (Details) - USD ($) $ in Millions	Jun. 30, 2019	Mar. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Intangibles, net		$ 2,029	$ 1,455
FGL [Member] | Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		16
Finite-Lived Intangible Assets, Accumulated Amortization		4
Finite-Lived Intangible Assets, Net		12
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
FGL [Member] | Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		6
Licensing Agreements [Member] | FGL [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, net		$ 6

Intangible Assets - Narrative (

Intangible Assets - Narrative (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Unearned Revenue, Net	$ (87)	$ (39)
Unearned Revenue, Unlocking Adjustment	1	0
Goodwill	$ 467		$ 467
Document Period End Date	Mar. 31, 2020
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	$ 39	0
Unearned Revenue, Additions	(12)	(9)
Unearned Revenue, Amortization Expense	(2)	2
Interest Expense	(1)
Unearned Revenue, Unrealized Gain (Loss) on Investment	$ (30)	9
Minimum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset	0.05%
Maximum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset	4.01%
Voba [Member]
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains	$ (155)	(40)
Dac [Member]
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains	(9)	(5)
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	$ 10	$ 2

Intangible Assets - Estimated A

Intangible Assets - Estimated Amortization Expense for VOBA in Future Fiscal Periods (Detail) $ in Millions	Mar. 31, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2019	$ 63
2020	86
2021	83
2022	74
2023	66
Thereafter	$ 347

Debt - Narrative (Detail)

Debt - Narrative (Detail) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 543
Long-term Debt		$ 542
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	$ 0	$ 0
Interest rate if revolver drawn	3.74%	4.55%
Remaining borrowing capacity	$ 250	$ 250

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 543
Long-term Debt		$ 542
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	$ 0	$ 0

Equity - Schedule of Dividends

Equity - Schedule of Dividends (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	Sep. 09, 2019	Aug. 07, 2019	Aug. 26, 2019
Accelerated Share Repurchases [Line Items]
Common stock, shares outstanding (in shares)			222,119
Cash dividend per common share (in dollars per share)		$ 0.01
Total cash paid	$ 2

Equity - Schedule of Dividend_2

Equity - Schedule of Dividends Declared (Details) $ / shares in Units, shares in Thousands, shareholder in Thousands, $ in Thousands	Dec. 15, 2020	Oct. 01, 2019USD ($)shares	Sep. 15, 2019shares	Aug. 07, 2019$ / shares	Apr. 01, 2018USD ($)shares	Mar. 15, 2018shareholder	Mar. 31, 2020USD ($)shares
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount							$ 150,000
Cash dividend per common share (in dollars per share) | $ / shares				$ 0.01
Total Stock Repurchased During Period, Shares | shares							8,652
Total Stock Repurchased During Period, Value							$ 69,000
Preferred Stock | Series A Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Number of Shareholders			321			298
Total cash paid		$ 0			$ 0
Total shares paid in kind (in thousands) | shares		6			6
Preferred Stock | Series B Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Number of Shareholders			117			108
Total cash paid		$ 0			$ 0
Total shares paid in kind (in thousands) | shares		2			2
Subsequent Event [Member]
Class of Stock [Line Items]
Stock Repurchase Program Expiration Date	Dec. 15, 2020

Stock Compensation - Narrative

Stock Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	Sep. 30, 2019	Mar. 31, 2020	Dec. 31, 2019	Aug. 08, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		5,714,000
2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)				15,006,000
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		0
Vested and exercisable at end of period (in shares)	1,467,000
Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value		$ 10.48	$ 0
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date		$ 1
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		95,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 10.48
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		95,000	0
Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value		$ 9.79	$ 9.02
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date		$ 5
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		456,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 10.87
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		(123,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value		$ 9.14
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		1,078,000	745,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities		$ 2
Director [Member] | Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		95,000
Management [Member] | Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		456,000
FGL Holdings [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Price		$ 9.80

Stock Compensation - Schedule o

Stock Compensation - Schedule of Stock Based Compensation Costs (Details) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Related tax benefit	$ 1
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	2
Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	3
Management Incentive Plan [Member] | Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date	$ 5
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares	0
FGL Incentive Plan [Member] | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date	$ 1

Stock Compensation - Summary of

Stock Compensation - Summary of Unrecognized Stock Compensation Expense (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 27
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	3 years
FGL Incentive Plan [Member] | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 17
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	3 years
Management Incentive Plan [Member] | Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 10
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	2 years

Stock Compensation - Summary _2

Stock Compensation - Summary of Stock Options Outstanding and Related Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	Sep. 30, 2019	Mar. 31, 2020	Dec. 31, 2019
FGL Incentive Plan [Member]
Options (in shares):
Stock options outstanding at beginning of period (in shares)		15,214
Granted (in shares)		0
Exercised (in shares)		0
Forfeited or expired (in shares)		(97)
Stock options outstanding at end (in shares)		15,117
Vested and exercisable at end of period (in shares)	1,467
Vested or projected to vest (in shares)		15,117
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (USD per share)		$ 9.30
Granted (USD per share)		0
Exercised (USD per share)		0
Forfeited or expired (USD per share)		10
Stock options outstanding at end of period (USD per share)		9.30
Vested and exercisable at end of period (USD per share)	$ 9.31
Vested and projected to vest (in dollars per share)		$ 9.30
Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		95	0
Options (in shares):
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date		$ 1
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value		$ 10.48	$ 0
Granted (in shares)		95
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 10.48
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value		$ 0
Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		1,078	745
Options (in shares):
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date		$ 5
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value		$ 9.79	$ 9.02
Granted (in shares)		456
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 10.87
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		(123)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value		$ 9.14
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value		$ 0

Stock Compensation - Summary _3

Stock Compensation - Summary of Options Subject To Vesting Conditions (Details) shares in Thousands	Mar. 31, 2020shares
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested or projected to vest (in shares)	15,117

Stock Compensation - Assumption

Stock Compensation - Assumptions Used in Determination of Grant Date Fair Values Using Black-Scholes Option Pricing Model (Details) - Equity Option [Member] - FGL Incentive Plan [Member]	3 Months Ended
	Mar. 31, 2020
Service Vesting Mechanism [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.53%
Assumed dividend yield	0.46%
Expected option term	4 years 6 months
Service Vesting Mechanism [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.48%
Assumed dividend yield	0.56%
Expected option term	5 years 9 months 18 days
Service and Return on Equity Performance Vesting Mechanism [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.53%
Assumed dividend yield	0.46%
Expected option term	4 years 9 months 18 days
Service and Return on Equity Performance Vesting Mechanism [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.50%
Assumed dividend yield	0.56%
Expected option term	6 years
Service and Stock Price Performance Vesting Mechanism [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.62%
Assumed dividend yield	0.46%
share-based compensation arrangement by share-based payment award, fair value assumptions, contractual term	6 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Cost of Equity	9.39%
Service and Stock Price Performance Vesting Mechanism [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.30%
Assumed dividend yield	0.56%
share-based compensation arrangement by share-based payment award, fair value assumptions, contractual term	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Cost of Equity	10.50%

Stock Compensation - Summary _4

Stock Compensation - Summary of Restricted Stock and Restricted Stock Units Outstanding and Related Activity (Details) - FGL Incentive Plan [Member] - Restricted shares shares in Thousands	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Shares:
Restricted shares outstanding at beginning of period (in shares) | shares	0
Granted (in shares) | shares	95
Vested (in shares) | shares	0
Restricted shares outstanding at end of period (in shares) | shares	95
Weighted Average Grant Date Fair Value (in dollars per share):
Average grant date fair value outstanding at beginning of period (USD per share) | $ / shares	$ 0
Average grant date fair value, Granted (USD per share) | $ / shares	10.48
Average grant date fair value, Exercised (USD per share) | $ / shares	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares	0
Average grant date fair value, Forfeited or Expired (USD per share) | $ / shares	$ 0
Average grant date fair value outstanding at end of period (USD per share) | $ / shares	$ 10.48

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Tax Credit Carryforward [Line Items]
Effective tax rate	0.00%	5.00%
Valuation allowance	$ 297
Deferred Tax Assets, Gross	$ 561

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Investment Commitments (Details) - Commitment to Invest $ in Millions	Mar. 31, 2020USD ($)
Other Commitments [Line Items]
Unfunded investment commitment	$ 1,452
Other invested assets
Other Commitments [Line Items]
Unfunded investment commitment	1,252
Fixed maturity securities, available-for-sale
Other Commitments [Line Items]
Unfunded investment commitment	111
Other assets
Other Commitments [Line Items]
Unfunded investment commitment	71
Residential Mortgage [Member]
Other Commitments [Line Items]
Unfunded investment commitment	$ 18

Commitments and Contingencies_2

Commitments and Contingencies - Narrative (Details) - USD ($)	Sep. 30, 2019	Mar. 31, 2020
Loss Contingencies [Line Items]
Accrued amount of guaranty fund assessments	$ 2
Estimated future premium tax deductions		$ 2

Reinsurance - Effect of Reinsur

Reinsurance - Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Effects of Reinsurance [Line Items]
Document Period End Date	Mar. 31, 2020
Benefits and Other Changes in Insurance Policy Reserves:
Net	$ (41)	$ 339
Traditional life insurance premiums
Premiums and other considerations:
Direct	50	57
Assumed	0	0
Ceded	(40)	(41)
Net	10	16
Benefits and Other Changes in Insurance Policy Reserves:
Direct	130	372
Assumed	(115)	20
Ceded	(56)	(53)
Net	$ (41)	$ 339

Reinsurance - Narrative (Detail

Reinsurance - Narrative (Details)	Jun. 28, 2019USD ($)	Dec. 28, 2018USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Ceded Credit Risk [Line Items]
Document Period End Date			Mar. 31, 2020
Reinsurance, Loss on Uncollectible Accounts in Period, Amount			$ 0	$ 0
Reinsurance Risk Charge Fee			$ 5
Number of policies reinsured by foreign company not engaged in insurance			0
Funds withheld for reinsurance receivables, at fair value			$ 2,050,000,000		$ 2,172,000,000
Funds Held under Reinsurance Agreements, Liability			821,000,000		831,000,000
Liability for Future Policy Benefit, before Reinsurance			5,658,000,000		$ 5,735,000,000
Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Ceded			0	$ 0
Reinsurance Retention Policy, Amount Retained	$ 185,000,000	$ 758
Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsurance Retention Policy, Amount Retained	$ 1,000,000,000	$ 4,000,000,000
FSRC
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value			266,000,000
Funds Held under Reinsurance Agreements, Liability			263,000,000
F&G Re [Member]
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value			1,784,000,000
Funds Held under Reinsurance Agreements, Liability			$ 1,641,000,000

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - USD ($) shares in Thousands	Sep. 30, 2019	Dec. 31, 2018	Dec. 17, 2018	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Related Party Transaction [Line Items]
Document Period End Date				Mar. 31, 2020
Related Party Transactions, Gain (Loss)				$ (3,000,000)	$ 0
Management Fee Payable				33,000,000		$ 47,000,000
Reimbursement Fees				3,000,000	$ 2,000,000
Related Party Transaction, Asset Carrying Value				1,978,000,000		2,001,000,000
Unrealized Loss on Foreign Currency Derivatives, before Tax	$ (5,000,000)	$ (3,000,000)
Commitment to Invest
Related Party Transaction [Line Items]
Unfunded investment commitment				1,452,000,000
Commitment to Invest | Affiliated Entity
Related Party Transaction [Line Items]
Unfunded investment commitment				$ 1,042,000,000		$ 993,000,000
Preferred Stock | Affiliated Entity
Related Party Transaction [Line Items]
Total shares paid in kind (in thousands)				6
Residential Portfolio Segment [Member]
Related Party Transaction [Line Items]
Residential Mortgage Loans Purchased			$ 89,000,000	$ 103,000,000

Earnings Per Share - Summary of

Earnings Per Share - Summary of Basic and Diluted EPS (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Document Period End Date	Mar. 31, 2020
Net income (loss)	$ (338)	$ 171
Less Preferred stock dividend	8	8
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic	$ (346)	$ 163
Weighted-average common shares outstanding - basic (in shares)	213,155,198	219,645,679
Dilutive effect of unvested restricted stock and unvested performance restricted stock (in shares)	0	36,000
Weighted-average shares outstanding - diluted (in shares)	213,155,198	219,681,679
Net income (loss) per common share:
Basic (in USD per share)	$ (1.62)	$ 0.74
Diluted (in USD per share)	$ (1.62)	$ 0.74
Common Stock Warrants Outstanding	6,000,000	6,000,000
Preferred Stock
Net income (loss) per common share:
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	438,000	406,000,000
Stock Option Awards
Net income (loss) per common share:
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	276,000	1,737,000

Insurance Subsidiary Financia_2

Insurance Subsidiary Financial Information and Regulatory Matters - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	$ 100
Non-permitted statutory accounting practices	(10)	$ (19)
Statutory capital and surplus	92	87
Increase (decrease) in statutory capital surplus	13	(110)
IOWA
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	$ 1	$ 6